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Ribonucleic acid (RNA), as one of the essential macromolecules of life, plays an 
active role in gene regulation, catalysis, and signaling because of its ability to adopt 
complex 3D structures that can exist in multiple conformations. Until now, RNA 
preparation methods devised by most investigators utilized partially denatured the 
RNA. The mis-folding caused by denaturing – renaturing can seriously affect RNA 
structure and functional activity. To test this hypothesis, in PART I of this 
dissertation, we presented a simple strategy using ‘click’ chemistry to couple biotin to 
a ‘caged’ photocleavable guanosine monophosphate to synthesize native RNAs that 
are properly folded. We demonstrated that RNA ribozymes, ranging in size from 27 
to 527 nt, prepared by our non-denaturing method form a homogenous population 
with superior catalytic activity than those prepared by traditional refolding methods.  
 Having developed a method for in vitro RNA synthesis, we studied the 
riboswitch family of RNAs that require remolding their structure for function in 
  
PART II. C-di-GMP riboswitch, as the only currently known secondary messenger 
riboswitch, senses c-di-GMP using its aptamer domain to modulate the expression of 
genes which affects biofilm formation and virulence factors production in bacteria. 
To specifically target pathogenic bacteria in polymicrobial systems that control the 
RNA-mediated c-di-GMP signaling pathway through riboswitch regulation, different 
c-di-GMP analogs have been used as chemical tools to investigate the 
structure-activity relationship (SAR) of c-di-GMP binding to different c-di-GMP 
riboswitches. We demonstrated that different 2’-position modified c-di-GMP analogs 
could differentiate between two different classes of c-di-GMP riboswitches and even 
bind to one particular riboswitch in class I with different affinities. 
 Specifically, Clostridium tetani (Ct-E88) RNA in class I c-di-GMP riboswitch 
was used for (structural dynamic) study to understand how ligand binding drives the 
conformational change to regulate the downstream genes within the expression 
platform. Our preliminary data obtained via different biochemical and biophysical 
tools – such as selective 2’-hydroxyl acylation analyzed by primer extension 
(SHAPE), small-angle X-ray scattering (SAXS) and nuclear magnetic resonance 
(NMR) spectroscopy – demonstrated that Mg
2+
 ions accelerate ligand recognition by 
pre-organizing the RNA, and then rapid ligand binding folds the RNA into a compact 
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PART I – Native RNA preperation 
Chapter 1: Introduction to Part I 
1.1 Introduction to ribonucleic acids (RNAs)  
The transfer of genetic information from deoxyribonucleic acids (DNAs) to 
proteins is one of the essential processes in living organisms. For a long time, 
ribonucleic acids (RNAs) had only been viewed as messengers that translate the 
genomic information, stored in DNAs, into proteins via mRNA transcripts. However, 
it is now appreciated that RNAs, including messenger RNA (mRNA), transfer RNA 
(tRNA), ribosomal RNA (rRNA), small nuclear RNA (snRNA) and other non-coding 







 in the cell. In fact, 
recent genomic sequencing efforts have indicated that protein coding sequences 
account for less than 2% of the human genomic output, whereas non-protein coding 
RNA sequences constitute at least 80% of that output.
7-10
  
Like DNA, ribonucleic acid (RNA) is also made up of a long chain of nucleotide 
blocks. Each nucleotide consists of a nucleobase, a ribose sugar, and a phosphate 
group (Figure 1.1). An important structural feature of RNA distinct from DNA is that 
RNA has a hydroxyl group at the 2’-position of the ribose sugar, which facilitates the 
degradation of RNA via an intramolecular in-line attack at the adjacent phosphate 









Figure 1.1. (A) Chemical Structure of RNA. (B) Chemical Structures of RNA bases. 
 
 
1.2 Traditional method to prepare RNA in vitro  
Given these peculiar and important features of RNA structure, it is not surprising 
that biochemical and biophysical studies of RNA are performed in vitro to gain 
valuable insights into RNA behavior in vivo. However, the in vitro studies of RNA 
structures and functions rely on the ability to prepare large amounts of RNA. In vitro 
transcription is a conventional RNA preparation procedure that allows for the 
synthesis of RNA molecules of any sequence from short oligonucleotides of less than 
100 nucleotides (nts) to several kilobases in microgram to milligram amounts from 
DNA templates.
12, 13
 The average rate of in vitro transcription is 200-260 
nucleotide/second.
14-16
 Traditionally, the DNA templates used for preparing RNA are 
plasmids that contain an insert of interest, double – stranded DNA (dsDNA) obtained 




templates contain a duplex T7 promoter site next to the transcription start site (Figure 
1.2). The most frequently used RNA polymerases (RNAP) for in vitro transcription 
are SP6, T3 and T7.
17
 The T7 RNAP, derived from the T7 bacteriophage of 
Escherichia coli (E. coli), is routinely used for transcription because it is efficient.
13
 
The T7 RNAP associates with the T7 class III promoter and initiates transcription 
with GTP or modified guanosine. The resulting RNA is then traditionally purified by 
phenol/chloroform extraction to remove associated proteins and denaturing 
polyacrylamide gel electrophoresis (PAGE) to separate RNAs of different lengths. 
The DNA templates, enzymes, nucleotides, and incomplete transcripts are removed 
efficiently using this purification protocol. However, because the T7 RNAP often 
appends one or even several extra nucleotides to the RNA 3’-ends, the full-length 
RNA transcripts are usually heterogeneous.
13, 18, 19
 Such micro-heterogeneous 
full-length transcripts are difficult to separate efficiently by denaturing PAGE 
separation. To eliminate 5’ and 3’ end heterogeneity, catalytic ribozyme fragments 
acting in cis or trans, such as hammerheads, can be placed at both ends of the RNA. 
The 5’ and 3’ flanking self-cleaving ribozymes will cut at a specific position during 









Figure 1.2. Three different types of DNA templates can be used for in vitro transcription. (A) 
A circular plasmid DNA with an insert coding for the RNA of interest cloned between a T7 
promoter and a unique restriction enzyme (RE) site is linearized and transcribed from the 
promoter. (B) A dsDNA template (plasmid, genomic DNA, cDNA or a cloned fragment) 
containing a T7 promoter acts as the template in PCR with a 5’-primer that is not 
complementary to the template  and 3’-primer that is complementary to the template. The 
resulting PCR-product is transcribed into RNA. (C) A short T7 promoter DNA 
oligonucleotide is annealed to an oligo that has the complimentary sequence fused to a DNA 
template sequence of interest. The partial dsDNA oligos can be transcribed into short RNAs. 
 
 
1.3 Problems associated with traditional RNA purification methods 
Clearly, these traditional RNA preparation and purification methods can be 




proteins, ethanol precipitation, heating in urea, denaturing PAGE separation based on 
size, and gel elution retrieval requires extensive denaturing-refolding cycles. 
However, recent studies indicate that this method generally creates heterogeneous 
active (native) or inactive (non-native) populations of conformers
23, 24
 and the 
heterogeneous conformation caused by misfolding from denaturation and renaturation 
cycles could seriously affect RNA structures and functions.
23-25
 For example, it has 
been demonstrated that in vitro denaturing and refolding process introduced severe 
conformational heterogeneity into the Varkud satellite (VS) ribozyme.
26
 In addition, 
denaturing PAGE purification of RNA also often leaves water-soluble acrylamide 
oligomers in the desired RNA product, which cannot be completely removed. The 
acrylamide oligomers bound to RNA could lead to an increase in molecular weight of 
the RNA and catalysis of base pair exchange through groove interactions to seriously 
affect NMR studies of RNA structure and dynamics.
27
 
The awareness of this problem is not new in the RNA field. What is new is 
sustained efforts to find a widely acceptable solutions to the problem of mis-folding 
caused by denaturing – renaturing.
26-36
 To date, several different methods, including 
affinity-capture release and chromatographic methods using size exclusion or weak 
anion-exchange methods based on size or charge, have been proposed to overcome 
this problem.
26, 27, 30-32, 35, 37, 38
 The affinity-capture release method uses high affinity 
tag ligands, which are immobilized on chromatography resins, to isolate the tag 
labeled RNA.
26, 28-32
 However, the most important factor to consider for RNA affinity 
tags is that the bound RNA can be eluted under native conditions without co-eluting 




often require very high concentration of monovalent salts (500-1000 mM) for eluting 
high molecular weight RNAs (>400 nt), but these non-physiological high salt 
concentrations may still partially misfold some RNAs.
33, 34
 Most chromatographic 
methods allow the efficient recycling of unincorporated NTPs, but they generally lack 
the high resolution necessary to obtain RNAs of very high purity. For example, 
HPLC is only appropriate for RNA of up to about 35 nt long because size exclusion 
requires a large size differences for separation. Furthermore, the RNAs produced 
from in vitro transcription reactions contain proteins that need to be removed by 
phenol/chloroform extraction before loading it on the column; otherwise the column 
bed may be coated with proteins and will lose its loading capacity over time. 
However, this phenol/chloroform extraction procedure also denatures RNA. More 
details on affinity-capture release methods and chromatographic methods have also 
been discussed in our recent publication (Chapter 2, Figure 2.1).
38
 
Due to the mis-folding problem in denaturing PAGE purification and the 
limitations of existing methods, our aim is to develop new methods that could 
improve native folded RNA preparation and aid in the studies of RNA structure and 
function. 
 
1.4 Newly developed native RNA preparation methods  
Affinity-capture release is a promising RNA preparation method, but it is 
desirable to obtain an untagged biomolecule after it has been isolated via affinity 
chromatography without altering the structure of the molecule. Biotin is often used as 








 The complex formed between biotin and 
avidin is essentially irreversible under a wide variety of conditions.
40
 Accordingly, 
biotin tags can be used to immobilize RNA to avidin solid supports and provide a 
means to separate desired labeled RNA from undesired unlabeled molecules. 
However, conventional methods that use biotin-affinity tags are limited by the 
difficulty of removing the affinity label from the target RNA. There are several 
methods of dissociation of biotinylated molecules from avidin capture probes. Firstly, 
biotin-avidin complex can be dissociated with 6-8 M guanidinium hydrochloride.
41
 
Secondly, biotin analogs with decreased affinity toward avidin (e.g., iminobiotin) can 
be utilized.
42
 Thirdly, biotin derivatives can be coupled with chemically cleavable 
spacer arms.
43-46
 However, none of these methods allow the release of target molecule 
in an unaltered form because the biotin or part of the cleavable spacer arm remains 
attached. In addition, these methods require harsh conditions which can denature the 
target RNA. In Chapter 2, we present a simple strategy using biotin coupled to 
photocleavable tags (PC tags) that circumvents many of the difficulties associated 




Our method uses Cu catalyzed 1, 3-dipolar Huigen’s cycloaddition reaction 
(‘click’ chemistry) to couple the biotin to a guanosine monophosphate with a 
photolabile nitrophenyl group
47
 (see Chapter 2). The polyethylene glycol (PEG) 
spacer is chosen to position the biotin moiety optimally from the GMP and to increase 
the water solubility of the modified GMP. On the basis of a previous finding of the 
guanosine-initiated transcription system
48




accept this ‘caged’ biotin guanosine monophosphate (referred to biotin-PC-GMP). 
RNAs with biotin-PC-GMP attached to their 5’ ends can be prepared in a 
straightforward manner by transcription priming.
49
 During transcription with the T7 
RNAP, nucleotides lacking a 5’-triphosphate cannot be incorporated into an 
elongating RNA chain, but they can be used to initiate a transcript, so transcription 
priming can produce a mixed population of modified and unmodified RNAs. To 
maximize analog incorporation, it is essential to include a large excess of 
biotin-PC-GMP over the corresponding unmodified nucleotide triphosphate (GTP). 
While this has the effect of increasing the fraction of population with the desired 5’ 
modification, it also tends to lower transcription efficiency. It is therefore generally 
necessary to empirically determine the appropriate modified GMP concentration to 
balance these factors needed for high yield of biotin-PC-GMP-RNA. Then only the 
RNA with biotin-PC-GMP tag binds to the avidin or streptavidin column and all the 
enzymes, NTPs and unlabeled RNA are washed away. Long wavelength UV (365 
nm), which does not damage RNA, can then be used to release the photocleavable 
biotin affinity tags. Since the RNA does not go through unfolding and refolding steps 
during photocleavable affinity purification, the purified RNA remains in its native 
form. Also, the RNA transcripts that are cleaved by UV have guanosine 
monophosphates at their 5’-ends, which can allow further ligations to other RNA 
fragments. 
The hypothesis that natively prepared RNA is likely catalytically more active 
than RNA prepared using denaturing methods that require heat-cooling and a 




model constructs (D1235 – 527 nt or D123 – 493 nt with D5 – 34 nt) from Pylaiella 
littoralis (PL).
34, 50
 Our results suggest that denaturing-refolding and native RNA 
preparation method makes a dramatic difference for the catalytic function of the D123 
or D1235 RNA ribozyme.
38
 Moreover, the results are in agreement with previous 
observations that RNA can be kinetically trapped in misfolded states which are not 







Chapter 2: RNA synthesized using photocleavable biotinylated 




The fundamental ability of RNA to switch between structures is a great asset for 
signaling, yet it can also become a liability when studying complex RNAs in vitro. 
Standard methods for RNA preparation typically denature the RNA, giving rise to 
heterogeneous populations of conformers.
23-25
 Preparation of RNA using these 
traditional protocols typically involves phenol chloroform extraction of associated 
proteins away from the RNA, RNA concentration by ethanol precipitation, heating in 
urea or formamide, and denaturing polyacrylamide gel electrophoresis (PAGE) 
fractionation. These established methods, while robust, may partially misfold the 
RNA and the resultant RNAs may retain only marginal activity.
23-25
 
Several methods recently proposed to overcome this problem have their own 
limitations.
26-35, 51
 These are summarized in Figure 2.1. The first group involves 
affinity capture-cleavage methods.
26, 28-32
 The second group of methods uses 
traditional protein chromatography methods of either size-exclusion
27, 35
 or weak 
anion exchange chromatography.
33, 34
 The size-exclusion methods allow efficient 
recycling of unincorporated NTPs and separation of RNA oligomers. However T7 
RNA polymerase (T7 RNAP) needs to be removed prior to chromatography using 
tedious phenol-chloroform extraction and desalting.
26, 35
 The weak anion exchange 




concentration of monovalent salts (500-1000 mM) for eluting high molecular weight 




Figure 2.1. Two broad methods for native RNA purification.
51
 (I) Affinity-capture 
release methods. (A) Native purification of RNA using self-cleaving DNAzyme affinity 
chromatography.
32
 The DNAzyme comprises a core structure of 15-nt flanked by arms of 7-13 
nt which can hybridize to the target RNA, and three-quarters of the DNA affinity tag is 
complementary to the target RNA.
32, 51
 (B) Schematic of protein-RNA affinity column.
31, 51
 
The RNA of interest is appended to a self-cleaving hepatitis delta virus (HDV) ribozyme 
(~68-nt) and a stem loop RNA motif (~100-nt) from a signal recognition particle (SRP) that 
binds tightly to the SRP protein, the Ffh-M domain. The transcribed RNA is run over an 
affiGel affinity column to which the Ffh protein has been immobilized. Addition of imidazole, 
~200 mM, cleaves the target RNA and enables elution of the RNA.  (C) Schematic of 
protein-RNA affinity column.
29, 51
 The RNA of interest is appended to a self-cleaving glmS 
Ribozyme (~140-nt) and a 43-nt MS2 coat protein binding RNA stem-loops upstream of the 
glmS Ribozyme. The transcribed RNA is run over the widely used Ni
2+
 affinity column to 
which a His-tagged form of the maltose binding protein (MBP)-MS2-CP coat fusion protein 
has been immobilized. Addition of 1mM Glc6NP cleaves the target RNA and enables elution 
of the RNA. (D) Schematic of an RNA affinity column.
30
 The RNA of interest is immediately 
downstream of a self-cleaving glmS Ribozyme (~211-nt) and a 20-nt RNA sequence that is 
complementary a biotinylated DNA capture sequence. The transcribed RNA complexed to the 




Addition of 1mM Glc6NP cleaves the target RNA and enables elution of the RNA. (II) 
Chromatographic methods using size exclusion or weak anion-exchange methods based 
on size or charge. 
 
 
Development of new methods that facilitate the preparation of RNAs under native 
conditions would complement existing methods and aid in studies that investigate the 
impact of natively folded RNA structure on function. To this end, we have developed 
a new method that uses ‘click’ chemistry
52, 53
 to couple biotin
43, 45, 46, 54
 to a "caged" or 
photolabile
55
 guanosine (hereafter referred to as biotin-PC-GMP) in high yield, and 









Scheme 2.1. Preparation of native RNA using biotin-PC-GMP as initiator 
(A) Schematic procedure for biotin-PC labeling of RNA during in vitro transcription. (B) 
Expected gel image for analysis of RNA labeling efficiency by PAGE (Two bands for 
biotin-PC-RNA- streptavidin complex shown are due to multivalent nature of streptavidin, i.e. 





We demonstrate the methodology on four RNAs ranging in size from 27-nt RNA 
fragment
58
 to a 530-nt ribozyme
50, 59
(Figure 2.2). Importantly, we show that the 
biotin-PC-GMP-synthesized ribozymes rapidly cleave fluorescently labeled substrates 
(in < 0.5 h) whereas the same ribozymes prepared using the conventional methods and 
refolded are unable to cleave the substrate after 2 h. These results underscore an 




methods can have reduced function making conclusions based on results from such 
preparations precarious. 
 
Figure 2.2. Secondary structures for the four RNAs studied. (A) The 494-nt D123 RNA. 
(B) The 530-nt D123-D5 RNA (36-nt D5 RNA connected in cis to 494-nt D123 RNA). (C) 
The 27-nt A-site RNA. 
 
 





All synthesis reactions were performed in oven-dried glassware under N2 
atmosphere and covered with aluminum foil, if not stated otherwise. 
Dimethylformamide (DMF) was dried using the PureSolv™ solvent purification 
system and MeCN was distilled from CaH2 and used immediately. All reactions were 
followed by TLC, unless stated otherwise. TLC analysis was performed by 
illumination with UV (254nm) or staining with p-anisaldehyde and heating. 
Purification of products by gel column chromatography was performed using 40-63 
μm silica gel. 2',3'-Diacetyl Guanosine (n-iBu) 5'-CED phosphoramidite (3) was 
obtained from Chemgenes Corporation and Biotin-dPEG
TM
 3+4 – azide (4) was 
obtained from Quanta BioDesign. 4-[4-(1-hydroxyethyl)-2-methoxy-5-nitrophenoxyl] 
butyric acid (1) and propargylamine were obtained from Sigma Aldrich. All NMR 
spectra were referenced to TMS (tetramethyl silane) and recorded on a Bruker 400 
MHz spectrometer at 25˚C. 
 
General procedures 





Scheme 2.2. Synthesis of biotin-PC-GMP using ‘click’ chemistry 
Reagents and conditions: (a) HOBt, HBTU, Et3N, DMF (s); (b) ETT, MeCN (s); (c) I2 
(THF/pyridine/H2O 7:2:1); (d) Na2S2O3; (e) 28-30% NH3·H2O; (f) CuSO4, isoascorbic acid, 




2.2.1 Synthesis of Photocleavable (PC) alkyne 
To a solution of 4-[4-(1-hydroxyethyl)-2-methoxy-5-nitrophenoxyl] butyric acid 
(1) (300 mg, 1 mmol., 1 eq) in dry DMF (6 mL) was added distilled propargylamine 
(0.26 mL, 4 mmol., 4 eq), HBTU (758 mg, 2 mmol, 2 eq), HOBt (67.5 mg, 0.5 mmol, 
0.5 eq) and Et3N (280 μL, 2  mmol, 2 eq). The mixture was stirred under nitrogen, at 
room temperature overnight. After completion of the reaction (as judged by TLC 
analysis), the solvent was removed under vacuum and the mixture was purified by 
silica gel column chromatography with a step gradient of MeOH (0.5-2.5%) in CHCl3. 




product 2 as a yellow solid (235 mg, 70%): 
1
H NMR (400 MHz, CDCl3) δ 7.49 (s, 
1H), 7.28 (s, 1H), 6.45 (s, 1H), 6.45 (br, 1H), 5.50 (q, J = 6.4 Hz, 1H), 4.05 (t, J = 4.0 
Hz, 2H), 4.00 (t, J = 2.4 Hz, 2H), 3.93 (s, 3H), 3.27 (br, 1H), 2.42 (t, J = 7.2 Hz, 2H), 
2.20 (d, J = 2.4 Hz, 1H), 2.17 (q, J = 6.8 Hz, 2H), 1.49 (d, J = 6.4, 3H); 
13
C NMR (100 
MHz, CDCl3) δ 172.6, 154.3, 147.0, 139.7, 138.0, 109.4, 109.1, 80.0, 71.9, 68.8, 65.9, 
56.7, 33.0, 29.5, 25.1, 24.9. ESI-MS：[M+H]+ calcd 337.1, found 337.1. (See 
Appendix 1) 
 
2.2.2 Synthesis of PC alkyne GMP 
a) Mixture of compound (2) (198 mg, 0.59 mmol, 1.5 eq) and ETT (153 mg, 1.18 
mmol, 3 eq) was dried under high-vacuum. Then, a solution of 2′,3′-Diacetyl 
Guanosine (n-iBu) CED phosphoramide (3) (250 mg, 0.39 mmol, 1 eq) in anhydrous 
CH3CN (3 mL) was added dropwise, under nitrogen. The reaction mixture was stirred 
at room temperature overnight. After completion of the reaction, the phosphite 
derivative was obtained as yellow oil after evaporation of the solvent and was directly 
used in the next step without purification.  
b) The crude phosphite derivative (2 eq) obtained from step a) was dissolved in the 
“oxidation” solvent (27 mL, 0.02 M I2 in 7:2:1 of THF:pyridine: H2O, 3 eq). After 
stirring at room temperature for 10 min, the reaction was quenched with Na2S2O3 (86 
mg, 0.54 mmol., 3 eq) in H2O (1 mL). Stirring was continued at room temperature for 
another 10 min during which the mixture turned from brown to a yellow color. The 
oxidized product (phosphate derivative) was obtained as yellow oil after evaporation 




c) A solution of 28-30% aqueous ammonia (35 mL) was added to the crude product 
obtained from step b. The reaction mixture was stirred at 65
o
C for 8 h. After 8 h, NH3 
was evaporated at room temperature for 3 h. The reaction mixture was subjected to 
HPLC purification.  
The mixture from step c was purified using a Varian HPLC fitted with a reverse 
phase C18 column (4.6 mm×250 mm, 5μm particle size). The reaction mixture 
components were eluted using linear gradients of solvent A (water) and B (100% 
acetonitrile) as follow: 5% to 15% B for 15 min, 15% to 40% B for 5 min, 40% to 
90% for 4 min, 90% B hold for 4 min, 90% to 5% B for 4 min and 90% B washing for 
3 min. The eluent was monitored using UV-Vis absorption at 254 nm. Data was 
collected and analyzed by galaxy software. Compound 5 eluted at 18-20 min. 
The collected fractions were lyophilized to yield the product 5 (66.39 mg, overall 
yield of 25% from compound 2): 
1
H NMR (400 MHz, D2O) δ 7.76 (s, 1H), 7.37 (d, J 
= 24.0 Hz, 1H), 7.25 (d, J = 9.6 Hz, 1H), 5.87 (m, 1H), 5.70 (s, 1H), 4.46-4.30 (m, 2H), 
4.14 (s, 1H), 4.03-3.93 (m, 8H), 2.56 (d, J = 2.0 Hz, 1H), 2.40-2.39 (m, 2H), 2.07-2.05 
(m, J = 5.2 Hz, 2H), 1.97 (s, 1H), 1.52-1.50 (m, 3H); 
13
C NMR (100 MHz, D2O) δ 
176.02, 175.98, 158.87, 153.94, 153.87, 153.78, 151.65, 151.34, 146.40, 146.35, 
138.46, 138.39, 137.71, 137.47, 135.40, 135.34, 109.50, 109.23, 108.82, 108.41, 88.34, 
87.51, 83.56, 83.18, 79.92, 74.45, 74.05, 72.06, 70.93, 70.52, 70.34, 70.12, 68.51, 
65.87, 56.50, 47.03, 32.53, 32.50, 29.12, 24.81, 24.11, 24.06, 8.60; 
31
P NMR (162 
MHz, D2O) δ 0.14, 0.46; ESI-MS: [M+H]
+
 calcd 682.2, found 682.2. (See Appendix 
2) 




2.2.3 Synthesis of biotin-PC- GMP 
To a solution of PC alkyne GMP (5) (46 mg, 0.0675 mmol, 1 eq) in THF/water 
(1:1, v/v, 3.5 mL), the following were added: biotin-dPEG
TM
 3+4 – azide (48.6 mg, 
0.0675 mmol, 1 eq), CuSO4·5H2O (3.37 mg, 0.0135 mmol, 0.2 eq), and isoascorbic 
acid (23.8 mg, 0.135 mmol, 2 eq). The reaction mixture was stirred at room 
temperature for 5 h, and then subjected to HPLC purification.  
The mixture that was obtained after the azide alkyne Huisgen cycloaddition 
(‘click reaction’) was purified using HPLC C18 reverse phase column. Reaction 
mixture components were eluted using linear gradient of solvent A (water) and B 
(100% acetonitrile) as follow: 5% to 20% B for 8 min, 20% to 40% B for 12 min, 40% 
to 90% B for 2 min, 90% B hold for 2 min, 90% to 5% B for 2 min and 5% B washing 
for 2 min. The eluent was monitored using UV-Vis absorption at 254 nm. Data was 
collected and analyzed by galaxy software. Compound 6 eluted at 16-17 min.  
The collected fractions were lyophilized to yield the product 6 (80.32 mg, 85%). 
1
H NMR (400 MHz, D2O) δ 7.93 (s, 1H), 7.81 (br, 1H), 7.41-7.26 (m, 4H), 5.97-5.88 
(m, 1H), 5.73 (t, J = 4.6 Hz, 1H), 4.61-4.33 (m, 7H), 4.15-3.89 (m, 9H), 3.77-3.54 (m, 
27H), 3.31-3.21 (m, 6H), 2.97 (dd, J = 13.0, 5.0 Hz, 1H), 2.78 (d, J = 13.0 Hz, 1H), 
2.52-2.45 (m, 4H), 2.24 (t, J = 7.2 Hz, 2H), 2.13-2.08 (m, 2H), 1.94 (s, 2H), 1.82-1.52 
(m, 11H), 1.39-1.36 (m, 2H), 1.31 (t, J = 7.32 Hz, 2H); 
13
C NMR (100 MHz, D2O) δ 
176.86, 175.90, 175.87, 174.14, 165.61, 158.90, 154.00, 153.87, 153.76, 146.50, 
146.44, 138.58, 138.53, 135.41, 124.55, 109.57, 109.32, 108.79, 108.39, 88.35, 87.54, 
83.33, 74.55, 74.14, 70.39, 69.98, 69.94, 69.88, 69.86, 69.77, 69.12, 68.84, 68.73, 




36.46, 35.91, 34.79, 32.49, 28.69, 28.36, 28.10, 25.59, 25.00, 24.22, 8.66; 
31
P NMR 
(162 MHz, D2O) δ -0.03, -0.35; ESI-MS: [M+H]
+
 calcd 1401.57, found 1401.53. (See 
Appendix 3) 
 
2.2.4 Optimization of ribosomal A-site RNA and D5 RNA transcription  
RNAs were synthesized by in vitro transcription with T7 RNAP from a synthetic 
DNA template (Integrated DNA Technologies)
56
. The T7 RNAP was expressed in 
Escherichia coli BL21 (DE3) and purified on a Ni-chelating Sepharose column 
(Pharmacia). The T7 RNAP promoter sequence was 5′ - CTA ATA CGA CTC ACT 
ATA G - 3′. The template strand of ribosomal A-site
58
 was 5′- GmGmC GAC TTC 
ACC CGA AGG TGT GAC GCC TAT AGT GAG TCG TAT TAG- 3′ and the 
template strand of the D5 RNA
50, 59
 was 5′- g AAC CGT ACG TGC GAC TTT CAT 
CGC ATA CGG CTC c TAT AGT GAG TCG TAT TAG -3′. Two terminal 
2′-O-methyl modifications in the template strand indicated by “m” were introduced to 
substantially reduce the amount of transcripts with extra nucleotides at the 3′-end.
60
 
The lower case letters represent additional nucleotides introduced to improve 
transcription yield.
61
 All the purchased DNA strands were purified by denaturing 
PAGE. The transcription conditions for each RNA were optimized by varying the 
[A/C/UTPs] and ratio of [GTP]/[ biotin-PC-GMP] in transcription buffer B [40 mM 
Tris-HCl (pH 8.1), 1 mM spermidine, 10 mM dithiothreitol (DTT), 0.01% Triton 
X-100, 80 mg/mL PEG 8000, 0.2 units of RNase inhibitor (New England Biolabs), 0.2 
units of inorganic pyrophosphatase (New England Biolabs)] containing 15 mM Mg
2+
, 




transcription volume. The reactions were incubated for 4 h at 37˚C. After 4 h, 0.2 units 
of Turbo DNase (Ambion) were added and the samples were incubated for another 15 
min. The RNA transcripts were immediately analyzed on a 12% denaturing PAGE/8M 
urea/1×TBE gel and stained with ethidium bromide (EtBr). 
 
2.2.5 Streptavidin-biotin-PC-D5-RNA gel shift experiment 
After the removal of unused biotin-PC-GMP, the purified biotin-PC-D5-RNA was 
incubated with three-fold molar excess of streptavidin (Promega) (with respect to 
RNA) at 37°C for 1 h. After incubation, the sample was split into two equal parts, one 
was irradiated with UV light at 365 nm for 1 h and the other half was left on the 
benchtop for 1 h. Each set was loaded into a tube containing a 0.5 mL ultra spin filter 
with a molecular weight cut-off (MWCO) of 10 kDa (Millipore-Amicon), followed by 
washing with 500 μL of double-distilled water. This wash step was repeated three 
times; the flow-throughs were combined, concentrated, and analyzed through a 12% 
denaturing PAGE. 
 
2.2.6 Purification of biotinylated RNA with Neutravidin-agarose resin and 
photocleavage 
A 20 µL transcription mixture was loaded into a tube containing a 0.5 mL ultra 
spin filter with a MWCO of 3 kDa (Millipore-Amicon), followed by washing with 500 




6.4). This wash step was repeated three times to completely remove unincorporated 
free biotin-PC-GMP from the transcription reaction. 
The transcription mixture was added to a suspension of NeutrAvidin Agarose 
Resin solution (Thermo Scientific, IL) and pre-equilibrated in potassium phosphate 
buffer (0.1 M phosphate, 0.15 M potassium chloride, pH 6.4). After 1 h incubation, 
the column was washed with 8-10 column volumes of potassium phosphate buffer to 
remove all unbound molecules. The bound biotin-PC-RNA on the resin was 
subsequently irradiated with UV light at 365 nm for 1 h. After irradiation, the sample 
in the column was eluted with 8-10 column volumes of potassium phosphate buffer.  
All the fractions were pooled, concentrated and analyzed by UV absorption 
spectroscopy at 260 nm. The pooled fractions were then separated through 8M urea 
denaturing PAGE.  
 
2.2.7 Native D123 (GTP-D123) RNA sample preparation  
D123 RNA was transcribed from template DNA produced by PCR amplification 
from the original plasmid containing domains 1-3 (D1 to D3).
50
 D123 template was 
amplified using an upstream primer containing the T7 RNAP promoter sequence and 
the first 19 nt from the 5′-end of the D1 sequence and a downstream primer containing 
19 nt of the 3′-end of the intron domain 3. The RNA was transcribed in transcription 
buffer B containing 3.33 mM each ATP, CTP and UTP, 2 mM GTP, 8 mM 
biotin-PC-GMP, 24 mM Mg
2+
, 1.5 μg of gel purified PCR template, and 10 μL of T7 
RNAP (4 mg/mL) per 200 μL of reaction volume. After 4 h, 0.2 units of Turbo DNase 




D123 RNA was affinity purified as described above. UV absorbance at 260 nm was 
used to calculate the concentration based on the extinction coefficients of the 
individual nucleotides.  
 
2.2.8 Native D1235 (GTP-D1235) RNA sample preparation  
D1235 RNA was transcribed from template DNA produced by PCR amplification 
from the original plasmid containing domains 1, 2, 3, and 5 as described.
34
 The RNA 
was transcribed and affinity purified as described above. RNAs produced from PCR 
transcripts were determined to be identical to those prepared from plasmids and the 
two methods gave similar RNA yields. 
 
2.2.9 Gel purified D5 RNA sample preparation 
The D5 RNA was synthesized as described above in transcription buffer B 
containing 10 mM total NTPs and 15 mM Mg
2+
, and was purified by 12% denaturing 
PAGE. The product band was detected by brief UV-shadowing, excised and 
electro-eluted in an Elutrap electro-separation system (Schleicher and Schuell). The 
purified D5 RNA was precipitated with three volumes of absolute ethanol and 0.3 M 
sodium acetate pH 5.2. The RNA pellet was then dissolved in water and dialyzed in a 
Biodialyzer (Nestgroup) with a 500 Da MWCO membrane (Nestgroup). Each dialysis 
step was performed for 12 h against dialysis buffer A (100 mM potassium phosphate 
at pH 6.4, 10 mM EDTA, 0.5 M KCl), B (100 mM potassium phosphate at pH 6.4, 1 




EDTA, 0.1 M M KCl), and finally against two changes of double-distilled H2O. Note 
that the denaturing preparation method just described may take about 2-3 days which 
contrasts with our native preparation method described earlier that is completed 4-6 h 
after the transcription reaction. After dialysis, the RNA was lyophilized.  
 
2.2.10 Gel Purified D123 RNA (GTP-D123 RNA) and D1235 RNA (GTP-D1235 
RNA) sample preparation 
D123 RNA was transcribed from DNA produced by PCR amplification as 





 Similarly D1235 RNA was transcribed from DNA produced by PCR 
amplification as described above using transcription buffer B containing 10 mM total 
NTPs and 18 mM Mg
2+
. Each resulting RNA was gel-purified as described above for 
D5 RNA, except that a denaturing 6% gel was used. 
 
2.2.11 Anion exchange purified D123 RNA (GTP-D123 RNA) and D1235 RNA 
(GTP-D1235 RNA) sample preparation.  
The in vitro transcription reaction mixture was incubated with 0.2 U of Turbo 
DNase at 37°C for 0.5 h. A 1 mL reaction mixture was pelleted to remove inorganic 
pyrophosphate and the supernatant was loaded into a 1 mL loop of an AKTA FPLC 
purifier system (GE Healthcare) connected to a 5 mL HiTrap Q column (GE 
Healthcare). The column was equilibrated with 4 column volumes of buffer A1 (20 




chromatography was performed with buffer A2 (20 mM KH2PO4, 2 M KCl, 100 M 
EDTA, pH 6.50), generating a gradient by simultaneously decreasing the 
concentration of buffer A1 and increasing the concentration of buffer A2. The 
separations were collected as 5 mL fractions with the following gradients of elution: 
0-30 mL for injection and loop washing (0% A2), 30-80 mL for washing off rNTPs 
and proteins (0-17% A2 at 2 mL/min), 80-110 mL for washing off small abortive 
transcripts (17-27% A2 at 2 mL/min), 110-175 mL for eluting RNA off the column 
(27-60% A2 at 2 mL/min). The column was further washed with 50 mL of buffer A2 
for the next cycle of purification. Fractions were analyzed by 8% PAGE containing 
8M urea. 
 
2.2.12 Labeling E1E2 substrate RNAs with Alexa 647 fluorophore 
For the fluorescence studies, Alexa 647 carboxylic acid succinimidyl ester 
(Invitrogen/Molecular Probes Inc.) was site-specifically incorporated at the 5′-end of 
E1E2 RNA, which comprises the last 16 nt of the 5′-exon (E1) and the first 6 nt of the 
3′-exon (E2), via a primary amine C-6 linker (A647-C6 linker-5′-GAC UGU UUA 
UUA AAA A↨CAC AGG-3′ (Dharmacon Inc); the cleavage site is indicated by ↨).
50
 
This labeled RNA (22 nt) is hereafter referred to as A647-E1E2 RNA. The RNA was 
labeled using 10-15 molar excess of the dye in 0.1 M sodium tetraborate (pH 8.5) at 
room temperature for 12 h with gentle mixing. The resulting A647-E1E2 RNA was 
purified using a denaturing 15% gel prior to electroelution. The eluted RNA was 
ethanol-precipitated and dissolved in 500 μL of MOPS buffer (40 mM MOPS at pH 




described above, and several times in double-distilled H2O before lyophilizing and 
dissolving in MOPS storage buffer (40 mM MOPS at pH 7.5, 100 mM KCl). 
 
2.2.13 RNA refolding protocol 
Previous work on group II introns indicated the importance of properly folding 
D123 and D1235 RNAs to obtain efficient catalytic cleavage as described above.
34, 50
 
For each model system, the following RNA refolding protocol was used as described 
previously
34, 50
: Each component RNA in buffer D (40 mM MOPS-K, pH 7.5, and 100 
mM KCl) was heated to 90°C for 1 min, allowed to cool to 42°C for 0.5 h, prefolded 
for various times (0, 5, 10, 20, 30, 60, 120 min) in 1M KCl and 50 mM MgCl2, and 
then the separately folded RNAs were combined to initiate the SER reaction.
34, 50
 We 
found that 2 h was necessary for prefolding and so all subsequent experiments were 
performed using 2 h of folding. Another set of SER reactions were carried out without 
this elaborate heat denaturation and refolding protocol. Instead each component RNA 
in buffer D was incubated at 42°C for 0.5 h, and then all the RNA components were 
combined in high salt buffer (40 mM MOPS-K, pH 7.5, 1 M KCl, and 50 mM MgCl2) 
to initiate the spliced extron reopening (SER) reaction. 
 
2.2.14 Cleavage of A647-E1E2 RNA substrate using gel, anion exchange or 
affinity purified D123 RNAs monitored by an in-gel shift experiment  
The spliced exon reopening reaction (SER)
50, 62
 was carried out at 42˚C with 




biotin-PC purified. The reaction used 1.46 μM D123, 2 μM D5, and 16 nM 
A647-E1E2 RNA in 50 mM MgCl2, 40 mM MOPS-K (pH 7.5) and 1M KCl. For one 
set of experiments, GTP-D123, anion exchange purified GTP-D123, and 
biotin-PC-GMP-D123 RNAs were prefolded using the RNA refolding protocol 
described above (with heating and cooling) in 50 mM MgCl2 at 42˚C for 2 h before 
adding D5 and substrate RNAs to initiate the SER reaction. For another set of 
experiments, GTP-D123, anion exchange purified GTP-D123, and 
biotin-PC-GMP-D123 RNAs were not prefolded (i.e. no heating and cooling), but 
allowed to incubate at 42˚C for 30 min before adding D5 and substrate RNAs to 
initiate the SER reaction. In either case, each reaction was incubated at 42˚C for 
various times (0, 2, 4, 8, 30, 60, 120, 240 min), and 5 μL of the reaction mixture was 
aliquoted into a stop buffer (50% glycerol and 100 mM EDTA), and loaded onto a 
denaturing 12% polyacrylamide gel. The Alexa-Fluor 647 RNA band was then 
quantified using a fluorescence scanner (Molecular Dynamics Storm 860) equipped 
with 635- and 450- nm diode pumped solid-state lasers.  
 
2.2.15 Cleavage of A647-E1E2 RNA substrate using gel, anion exchange or 
affinity purified D1235 RNAs monitored by an in-gel shift experiment 
The SER reactions
50, 62
 were carried out at 42˚C with gel, anion exchange, or 
biotin-PC purified D1235 (1.5 μM) using 16 nM A647-E1E2 RNA substrate in buffer 
D. The A647-E1E2 RNA substrate was heated at 90˚C for 2 min separately, and 
incubated at 42˚C in a water bath for 30 min.
50
 Before adding the substrate to initiate 




prefolded using the RNA refolding protocol or not refolded as described above for 
D123. Again the reaction was incubated at 42˚C for various times (0, 2, 4, 8, 30, 60, 
120, 240 min), 5 μL of the reaction mixture was aliquoted into a stop buffer (50% 
glycerol and 100 mM EDTA) and loaded onto a denaturing 12% polyacrylamide gel. 
The Alexa-Fluor 647 RNA band was then quantified using a fluorescence scanner as 
described above. The fraction of the A647-E1E2 RNA substrate cleaved at each time 
point was quantified and fitted to an exponential function using SigmaPlot 11.0. 
 
2.2.16 D123 RNA analyzed on native gel 
The gel purified, anion exchange purified and biotin-PC purified D123 were 
analyzed on 6 % native PAGE with 0.5×TME (12.5 mM Tris/MOPs, 0.1 mM EDTA) 
as the running buffer at 4˚C. To ensure the accurate determination of the RNA 
concentrations loaded on the gel, a small amount of sample was completely 
hydrolyzed in 1.0 M sodium hydroxide at 65°C for 2 hours, and the UV absorbance 
was used to calculate the concentration. To rule out overloading on the gel, two 
concentrations of RNAs were used: 1 μM and 3 μM for each RNA. 
 
2.3 Results and Discussion 
2.3.1 General Concept 
The traditional method of synthesizing RNAs in vitro typically involves 
denaturation during purification followed by a refolding step. This method implicitly 




several methods have been developed recently to purify RNAs without denaturation, 
very few studies have examined how the manner of RNA preparation affects both the 
folding and the function of the RNA. To show that the manner of RNA preparation 
can remarkably affect function such as catalysis, we proceeded to develop a simple 
strategy to make biotinylated GMP Scheme 2.1 which can be used to prime RNA 
synthesis. This strategy also allows for complete removal of the biotin moiety without 
leaving any non-natural chemical entity appended to the RNA. Importantly we show 
for the first time that large complex RNAs that are prepared by denaturing methods, 
and subsequently refolded, are catalytically less active than those prepared using 
native methods. 
 
2.3.2 Synthesis of biotin-PC-GMP 
Rationale: Results from previous studies have indicated that nucleoside 
monophosphates modified with an affinity label such as biotin can be used to prime 
RNA synthesis.
57, 63-65
 Once made, the RNA has to be cleaved from the biotin label. 
None of these previous methods provide a means to remove the biotin tag without 
leaving any trace. Therefore we have devised a facile strategy that allows efficient 
biotinylation of RNA, provides a traceless means to remove the biotin after the 
purification, and allows preparation of natively folded RNAs.  
The synthesis of the biotin-PC-GMP 6 is depicted in Scheme 2.2. The 
photosensitive precursor 1 was coupled with propargylamine to produce the 
PC-alkyne 2. Then compound 2 and protected GMP 3 were reacted to produce an 




The PC-alkyne GMP 5 was then coupled to biotin-dPEG
TM
 azide 4 through azide 
alkyne Huisgen cycloaddition ‘click’ chemistry using Cu(I) catalyst,
34, 53
 and the final 
product biotin-PC-GMP 6 was obtained in 85% overall yield starting from 5. The 
polyethylene glycol (PEG) spacer was chosen to increase the water solubility of 
biotin-PC-GMP and also to position the RNA further away from the biotin as the 
RNA could interfere with the biotin-neutravidin interactions during the 
immobilization step. 
 
2.3.3 T7 RNAP accepts biotin-PC-GMP 
Biotin-PC-GMP 6 was designed for direct incorporation into RNA by in vitro 
transcription catalyzed by T7 RNAP. To demonstrate that T7 RNAP accepts 
biotin-PC-GMP, we transcribed four different RNAs of varying size: a 27-nt A-site 
RNA fragment
56
 as well as three group II intron-derived RNAs
34, 50, 59
, i.e. a 36-nt D5 
RNA, a 493-nt D123 RNA comprising domains 1, 2, 3, and a 530-nt D1235 RNA 
comprising domains 1, 2, 3, and 5 (Figure 2.2).  
Visualization of the reaction product by 12% denaturing PAGE demonstrated that 
the initiator GMP was incorporated into the 36-nt D5 RNA. Lane 1 (Figure 2.3A) 
shows the D5 RNA synthesis without 6, and Lane 2 (Figure 2.3A) shows the 
transcription with 4 mM of initiator 6, demonstrating that T7 RNAP is able to initiate 
transcripts with the photolabile biotinylated nucleotide monophosphate (Figure 2.3A: 
Lanes 2) to make the photolabeled D5 RNA. A maximum incorporation of ~17% was 
achieved using 4 mM of the initiator 6 and 1 mM GTP. Interaction of this 




evaluated by mixing streptavidin agarose beads with the RNA, separating the beads 
from solution by filtration, and irradiating the beads with UV light at 365 nm. Lane 3 
(Figure 2.3A) demonstrates that the wash from the streptavidin column is identical to 
5′-GTP-RNA loaded on the column (Figure 2.3A: Lane 1). Lane 4 indicates that the 
5′-biotin-PC-GMP-RNA is retained on the column (cf. Lane 2) and only the unlabeled 
5′-GTP-RNA is washed off the column (Figure 2.3A: Lanes 4). The 
5′-biotin-PC-GMP-RNA bound to the column (Figure 2.3A: Lanes 4) was released in 
the wash following photocleavage (Figure 2.3A: Lane 6). As expected, 5′-GTP-RNA 
was not present in the wash following photocleavage (Figure 2.3A: Lane 5). These 
results also show that photocleavage does not degrade the RNA (Figure 2.3A: Lanes 
6; Figure 2.3B: Lane 4).  
 
 
Figure 2.3. Denaturing PAGE assay for biotin-PC modified D5 RNA. (A) Transcription of 
D5 RNA with (+) or without biotin-PC-GMP (-) followed by purification of the D5 RNA 
(GTP-D5 or biotin-PC-GMP-D5 RNA) with an avidin column after photocleavage. Lane 1: 
Transcription of D5 with unmodified GTP (I); Lane 2: Transcription of D5 with 
biotin-PC-GMP/GTP mixture (II); Lane 3: Streptavidin column flow-through of unlabeled 
GTP-D5 RNA; Lane 4: Streptavidin flow-through of biotin-PC labeled D5 RNA. As expected 
unlabeled GTP-D5 is washed off the column. Lane 5: Elution of the RNA on the streptavidin 
column following photo cleavage of unlabeled D5 RNA. As expected there is no unmodified 
D5 RNA left on the streptavidin column following the initial wash shown in lane Lane 3. Lane 
6: Elution of the RNA on the streptavidin column following photo cleavage of biotin-PC 




as GMP-D5 RNA that now runs at almost the same position as the unmodified GTP-D5 RNA. 
The RNAs are depicted as: GTP transcribed RNA (I), biotin-PC transcribed RNA (II). (B) 
RNA biotinylation assay with streptavidin. Lane 1: Unlabeled D5 RNA; Lane 2: Biotin-PC 
labeled D5 RNA; Lane 3: Biotin-PC labeled D5 RNA incubated with excess streptavidin 
(three times number of moles to RNA) for 1 h. Lane 4: GMP-RNA, flow-through using 10K 
MWCO spin filter after photocleavage of streptavidin-biotin-PC-RNA  
 
 
To rule out any subtle UV damage effects, we compared the FPLC UV 
chromatogram of a mixture of all four nucleotide triphosphates that were either 
irradiated with UV light at 365 nm or left on the desktop for 2 h. The FPLC traces for 
the irradiated and non-irradiated nucleotide mixture are completely superimposable 
with identical retention times, lineshapes, and intensity (Figure 2.4A). As a second 
test to rule out UV induced cleavage, we compared the mass spectrum of an RNA 
tetramer that was either irradiated with UV light or left on the desktop for 2 h; no 





Figure 2.4. No UV-induced RNA or NMPs damage through irradiation at 365 nm for 1-2 hrs. 
(A) HPLC traces of an NMP mixture (AMP/GMP/UMP/CMP) using the gradient MeCN%. 
NMPs mixture (AMP/GMP/UMP/CMP) was divided into three equal amounts. First portion 
was loaded on HPLC without UV shining (shown in blue); Second portion was irradiated by 
UV365nm for 1 hr before being loaded on HPLC (shown in green); Third portion was shined by 
UV365nm for 2 hrs before loaded on HPLC (shown in red). Three traces were exactly overlap, 
which indicated that there was no mutation with UV shining. (B) Linear negative mode 
MALDI-MS for four bases RNA (GUAC) before and after 2 hrs UV365 irradiation. Matrix: 
CHCA (α-cyano-4-hydroxycinnamic acid); [M-H]
-
 calcd 1223.8; before UV found 
[M-H+Na]
-
 at 1246.8; after UV found [M-H+Na]
-
 at 1247.1  
 
 
To further ascertain that the D5 RNA was indeed labeled with biotin-PC, the 
fractions were complexed to streptavidin and analyzed by denaturing PAGE (Figure 
2.3B). Given the strong affinity between biotin and avidin complexes, one of the 
strongest known in nature, (Kd of ~10
-15






 As expected, only the 5′-biotin-PC 
labeled RNA underwent a gel shift after incubation with streptavidin (Figure 2.3B: 
compare lanes 2 and 3). After photocleavage of these streptavidin-biotin-PC-GMP D5 
RNA complexes (irradiated for 1 h using UV light at 365 nm), the band migrated at 
almost the same position as the unmodified 5′-GTP-D5 RNA (Figure 2.3B, Lane 4).  
 
2.3.4 Transcription optimization of ribosomal A-site RNA and D5 RNA using 
unmodified GTP and biotin-PC-GMP 
As the modified GMP competes with unmodified GTP for transcription initiation, 
it is important to optimize the different concentrations of the three nucleotides ATP, 
CTP and UTP, as well as the different ratios of biotin-PC-GMP 6 to unmodified GTP 
in order to increase the transcription efficiency of biotin-PC-GMP 6. To quantify the 
incorporation efficiency of 6 by PAGE, a 27-nt A-site RNA and a 36-nt D5 RNA were 
used, as we had earlier observed that the electrophoretic mobility of the 
5′-biotin-PC-RNA transcripts differs from that of the unmodified 5′-GTP-RNA 
transcripts of these RNAs. Therefore, we reasoned that it would be straightforward to 
quantify the amounts of 5′-biotin-PC-GMP-RNA and the unlabeled RNA (i.e. 
5′-GTP-RNA) using these two RNAs. As the concentration of the biotin-PC-GMP was 
increased, a new band corresponding to the 5′-biotin-PC-RNA appeared that exhibited 
decreased mobility on PAGE. For quantification, the volumes of each of the peak 
positions on the gel were measured using the Quantity One software (Bio-Rad). 
Global background correction was applied using similar-sized rectangles for regions 




efficiency trials are shown in Figure 2.5 and Figure 2.6; those for the optimization of 
36-nt D5 RNA are shown in Figure 2.7.  
 
Figure 2.5. Enzymatic incorporation of the initiator biotin-PC-GMP with different ratios of 
biotin-PC-GMP: unmodified GTP using the ribosomal A-site DNA template. (A)  
Dependence of transcription priming of A-site RNA with biotin-PC-GMP on the ratios of 
biotin-PC-GMP : GTP in the presence of a total NTP concentration of 5 mM (i.e. 1.67 mM 
each ATP, CTP and UTP); n and n+1 products appeared for transcripts initiated with GTP 
and  biotin-PC analog. (B) Relative amounts of GTP- and biotin-PC-primed Asite RNA 
products transcribed in the presence of different ratios of biotin-PC-GMP : GTP at 1.67 mM 
each ATP, CTP and UTP. Each bar is based on an average of three experiments and the error 
bar is based on the standard deviation from 3 experimental repeats. Note: Incorporation yield 
is the amount of initiated transcripts divided by the total amount of transcripts for each band. 










Figure 2.6. Enzymatic incorporation of the initiator biotin-PC-GMP with different total 
concentrations of NTPs (ATP, CTP and UTP) using the ribosomal A-site DNA template. (A) 
Dependence of transcription priming of the A-site RNA with biotin-PC-GMP on the ratio of 
biotin-PC-GMP : GTP in the presence of total NTP concentrations of 3.5 mM (i.e. 1.167 mM 
each ATP, CTP and UTP), 5 mM (i.e. 1.67 mM each ATP, CTP and UTP) or 10 mM (i.e. 3.33 
mM each ATP, CTP and UTP). The double band in lane 1 represents n and n+1 GTP A-site 
RNA. The biotin-PC-RNA also migrated as two bands. (B) Trends of biotin-PC-RNA formed 
with the different concentrations of NTPs (ATP, CTP and UTP). The transcripts yield is based 
on the gel intensity. (C) Incorporation yield (the amount of initiated transcripts divided by the 
total amount of transcripts) of 5′-GTP-RNA and 5′- biotin-PC-GMP-RNA for each band in 
(A). Each bar is generated based on the average of three experiments and the error bar based 




Figure 2.7. Enzymatic incorporation of the initiator biotin-PC-GMP with different ratios of 
biotin-PC-GMP: unmodified GTP using the D5 template. (A) Dependence of transcription 





priming of D5 RNA with biotin-PC-GMP on the ratio of biotin-PC-GMP : GTP in the 
presence of 1.67 mM each ATP, CTP and UTP; (B) Relative amounts of GTP- and 
biotin-PC-primed D5 RNA products transcribed in the presence of different ratios of 
biotin-PC-GMP : GTP at 1.67 mM each ATP, CTP and UTP. Each bar is based on an average 
of three experiments and the error bar is based on the standard deviation from 3 experimental 
repeats. Note: Incorporation yield is the amount of initiated transcripts divided by the total 
amount of transcripts for each band.  
 
 
The overall yield of transcribed ‘biotin-PC primed’ A-site RNA was higher 
(~16 % incorporation yield) at 5 mM total NTP (ATP, CTP and UTP) concentration 
(Figure 2.5) than at 3.5 mM (~11 % incorporation yield) or 10 mM (~10% 
incorporation yield) total [NTP] concentrations (Figure 2.6). At the optimal 5 mM 
total concentration of NTP for 5′-biotin-PC-GMP-RNA incorporation, 28% of the 
transcribed RNAs were full-length 5′-GTP-RNA whereas abortive transcripts 
accounted for ~29% (Figure 2.6C). Note that the n+1 transcripts for the 5′-GTP-RNA 
and the 5′-biotin-PC-GMP-RNA were 20% and 7% respectively. The efficiency of 
transcription initiation was also analyzed using the DNA template for 36-nt D5 RNA. 
Again, as the concentration of biotin-PC-GMP was increased, a new band 
corresponding to 5′-biotin-PC-GMP D5 RNA appeared and migrated with decreased 
mobility on PAGE. A 17% yield (incorporation into the transcripts) of 
5′-biotin-PC-GMP D5 RNA transcripts was obtained at [biotin-PC-GMP] : 
[unmodified GTP] ratio of 4:1 and at 5 mM total NTP concentration (Figure 2.7). The 
results for A-site and D5 RNA transcription suggest that it is essential to optimize the 
NTP concentrations and to include a fourfold excess of biotin-PC-GMP over 





2.3.5 Purification of biotin labeled RNA with avidin affinity column and 
photocleavage 
To utilize the biotin-PC-RNA in functional or biophysical studies, the tag needs to 
be removed. To prevent the free biotin-PC-GMP from competing with the biotin 
labeled RNA for the Neutravidin-agarose resin binding, the unincorporated free 
biotin-PC-GMP was removed from the mixture using 3 kDa MWCO spin filters. The 
5′-tagged RNA was then immobilized on the Neutravidin-agarose resin and the 
unbound RNA (primarily unlabeled 5′-GTP-RNA) was washed off with phosphate 
buffer.  The RNA, bound to the resin, was then irradiated with UV light at 365 nm 
for 1 h to liberate the bound RNA (Figure 2.3A: Lane 6). 
 
2.3.6 Biotin-PC synthesized minimal group II intron ribozyme has enhanced 
catalytic activity compared to gel purified GTP-RNA in the SER reaction 
While a number of methods have been proposed to synthesize RNA under native 
conditions, it remains unclear how native RNA preparations affect function. To test 
the hypothesis that natively prepared RNA are more catalytically active than RNA 
prepared using denaturing methods that require heat-cooling refolding cycles, two 
variants of the minimal group II intron ribozyme splicing model system from Pylaiella 
littoralis (PL) were employed.
34, 50
 The first variant is a three-piece ribozyme system 
comprising D123, D5, and a substrate reflecting the product of exon ligation 
(A647-E1E2 RNA, 22-nt).
50
 In contrast, the second variant is a two piece ribozyme 
system comprising D1235 and the same substrate used with the three-piece system.
34
 




model because D5 is connected in cis rather than added in trans. For each model 
system, denatured GTP-RNA, anion-exchanged purified RNA, and ‘natively’ prepared 
biotin-PC-GMP-RNA were used in the spliced exon reopening reaction to test 
catalytic cleavage of the A647-E1E2 RNA.
34, 50, 62
 
The effect of heat denaturation and refolding on the D123 RNA to cleave the 
A647-E1E2 RNA substrate in the presence of D5 RNA were tested first (Figure 2.8A). 
In the absence of heat annealing, the natively prepared biotin-PC-GMP-D123 RNA 
was able to catalyze cleavage of the A647-E1E2 RNA substrate to near completion in 
~ 30 min (Figure 2.8B). Similarly natively prepared GTP-D123 RNA purified using 
anion exchange was able to catalyze near complete cleavage of the substrate in ~ 30 
min (Figure 2.8C), again underscoring the importance of native RNA preparation. In 
contrast, gel-purified GTP-D123 RNA required at least 180 min for complete cleavage 
(Figure 2.8D, H). These results suggest that the method of the RNA preparation 
makes a dramatic difference in D123 RNA ribozyme catalytic function; whereas 
cleavage by natively purified RNA was detectable within 2 min and was complete in 
less than 60 min, substantial cleavage by RNA purified by denaturing PAGE was not 
observed before 30 min and only reached completion after approximately 240 min 





Figure 2.8. (A) In-gel fluorescent assay for catalytic cleavage of a 22-nt spliced exon 
substrate (E1E2) by a minimal group II intron ribozyme comprising domains 1, 2, and 3 
(D123) and domain 5 (D5) or a ribozyme comprising domains 1, 2, 3, and 5 (D1235) in the 
presence of 50 mM Mg
2+
 at 42°C (SER reaction, for details, see Materials and methods); 
(B-D) Comparison of the catalytic activity of gel purified/anion exchange purified and 
(photo-cleaved) biotin-PC purified D123 and D5 RNA at no heat annealing (native) 
conditions; (E-G) Comparison of the catalytic activity of gel purified/anion exchange purified 
and (photo-cleaved) biotin-PC purified D123 and D5 RNA at heat annealing (refolding) 




experiment repeats. (H) Rates of buildup of cleaved A647-E1 product for no heat annealing 
SER reaction of D123 RNA were fitted into single-exponential function y=a*(1-exp(-b*x) 
using non-linear square minimization in SigmaPlot 11.0 sofeware. (I) Rates of buildup of 
cleaved A647-E1 product for heat annealing SER reaction of D123 RNA were fitted into 
single-exponential function. Error bars are generated based on standard deviation between 
2-3 experiment repeats. 
 
 
After heat annealing and refolding, the natively prepared biotin-PC-GMP-D123 
RNA cleaved the substrate in less than 60 min (Figure 2.8E), slightly more slowly 
than without the heat annealing procedure (Figure 2.8B, H). Similarly natively 
prepared GTP-D123 RNA purified using anion exchange cleaved the RNA substrate 
in ~ 60 min (Figure 2.8F). Here again the gel-purified GTP-D123 RNA required at 
least 2 h for complete cleavage (Figure 2.8G, I). In this case, cleavage began at ~ 8 
min instead of 30 min. These findings suggest that under conditions typically used in 
making folded RNAs, even heat annealing does not completely rescue the catalytic 
activity of the D123 RNA ribozyme. As shown below, folding is incomplete for the 
gel purified RNA. 
The effect of heat denaturation and refolding on the D1235 RNA to cleave the 
A647-E1E2 RNA substrate was employed as a second example of an RNA mediated 
catalysis. For this second model system the catalytic cofactor D5 RNA was connected 
in cis, and thus it was anticipated that this ribozyme would be catalytically more active 
and more robust in response to heat denaturation and refolding than D123. As 
expected, in the absence of heat annealing and refolding, the natively prepared 
biotin-PC-GMP-D1235 RNA was able to catalyze complete cleavage of the substrate 
in almost 30 min (Figure 2.9A). As observed for D123 RNA, natively prepared 
GTP-D123 RNA purified using anion exchange completely cleaved the substrate in ~ 




denatured and refolded for 2 h now required approximately 4 h for complete cleavage 
(Figure 2.9F). When the heating step was omitted, the endpoint of the reaction was 
reached at a comparable time period of ~4 h, but unlike the gel-purified GTP-D123 
RNA the onset of the reaction was only slightly retarded (Figure 2.8D, G, H, I versus 
Figure 2.9C, F, G, H). Altogether, these results suggest that conditions that are 
traditionally used in folding RNAs may not be as effective as envisioned especially in 
rescuing the catalytic activity of ribozymes. As shown below, folding is also 






Figure 2.9. (A-C) Comparison of the catalytic activity of gel purified/anion exchange purified 
and (photo-cleaved) biotin-PC purified D1235 RNA at no heat annealing (native) conditions; 
(D-F) Comparison of the catalytic activity of gel purified/anion exchange purified and 
(photo-cleaved) biotin-PC purified D1235 RNA at heat annealing (refolding) conditions 
respectively. (G) Rates of buildup of cleaved A647-E1 product for no heat annealing SER 
reaction of D123 RNA were fitted into single-exponential function y=a*(1-exp(-b*x) using 
non-linear square minimization in SigmaPlot 11.0 sofeware. (H) Rates of buildup of cleaved 
A647-E1 product for heat annealing SER reaction of D123 RNA were fitted into 







2.3.7 The population of biotin-PC synthesized minimal group II intron ribozyme 
conformers is more homogenous than that of gel purified GTP-RNA 
Using the native preparation method, the question of how different RNA 
preparation methods affects folding was examined. To test the hypothesis that natively 
prepared RNA should be more conformationally homogenous than RNA prepared 
using denaturing methods that require heat-cooling refolding cycles, samples of D123 
RNA prepared by urea PAGE (denatured and heat annealed as described earlier), 
anion-exchanged purified D123 RNA, and ‘natively’ prepared biotin-PC-GMP-D123 
RNA were analyzed by non-denaturing PAGE. Strikingly, the denaturing preparation 
had a significant impact on the migration pattern of the gel purified D123 RNA: even 
after refolding, >86% of the RNA was in alternative conformations (Figure 2.10). In 
contrast, ~93% of the ‘natively’ prepared biotin-PC-GMP-RNA, which had not been 
denatured, was in a homogenous conformation (Figure 2.10). Similarly ~85% of 
natively prepared GTP-D123 RNA purified using anion exchange was in homogenous 
conformation, with ~15% of the population in alternative slower migrating 
conformations (Figure 2.10). To rule out overloading of the gel purified D123 RNA, 
the experiment shown in Figure 2.10 was executed on 6% native PAGE using two 
different dilutions of all three RNAs tested. The concentrations of the RNAs were 
determined by UV absorbance measurements of RNAs hydrolyzed using NaOH to 
remove any hyperchromicity effects. As can be seen in Figure 2.10, the gel purified 
D123 RNA was consistently smeared, while the native preparations consistently 




Altogether, these results suggest that although the D123 or D1235 RNAs purified 
by denaturing PAGE conditions were heat annealed under conditions typically used in 
making folded RNAs, their catalytic activities were not completely rescued and most 
of the RNA existed in alternative conformations. These findings are in agreement with 
previous observations that RNA can be kinetically trapped in misfolded states which 





Figure 2.10. Comparison of gel purified, anion exchange purified and biotin-PC purified 
D123 on the 6% native PAGE gel with 0.5×TME（12.5 mM Tris/MOPs, 0.1 mM EDTA）as 
the running buffer at 4˚C. The boxed bands in blue represent the native RNAs and the smears 
part represent the non-native RNAs with heterogeneous conformations. There are two 




Experimental evidence is presented demonstrating that RNA enzymes not only 
fold differently but also have compromised catalytic activities depending on whether 
they were prepared using denaturing or nondenaturing purification methods. Although 
the RNA community has believed that large RNAs can become trapped into what has 
been described as the “alternative conformer hell”
24, 66




reveal the true extent of the problem have been heretofore performed. Standard 
methods for RNA preparation, while robust and well-established, can create not only 
heterogeneous populations of conformers,
24, 26
 but also produce RNAs that may 
become marginally active. The goal of this work was to develop a photolabile 
biotinylated nucleotide monophosphate strategy to facilitate native RNA preparation 
and to address the question of how the nature of the preparation can affect RNA 
function. This designed and synthesized biotin-PC-GMP was shown to be utilized by 
T7 RNAP as an initiator nucleotide to produce RNA labeled at the 5′-end with 
biotin-PC.  
This photoremovable affinity tag confers several desirable advantages for use in 
numerous RNA biophysical applications. First the ability to prepare “native” RNA 
without having to refold should minimize misfolding and thereby preserve the 
functionality of these RNAs. As proof of concept, we have shown that the two 
ribozymes prepared by our new method retain greater catalytic activity than when they 
were prepared by denaturing methods and have to be refolded. To determine if other 
native preparation methods would also give enzymatically more proficient RNAs, 
anion exchange was used to purify the RNAs under native conditions. As anticipated, 
RNAs purified via the native anion exchange method were almost as active as those 
prepared via the biotin-PC-GMP method. The biotin-PC-GMP native preparation is 
therefore a nice complementary method to other native RNA preparation methods 
such as anion exchange FPLC, and there is no panacea for preparing native RNAs. 
Importantly, this biotin-PC-GMP method does not require expensive instrumentation 




comparable to those reported recently which showed quite unambiguously that heating 
and subsequent cooling of a 164-nt Varkud satellite (VS) ribozyme led to ~70% 
slowly migrating non-native RNA folds, whereas a VS ribozyme purified under 
nondenaturing conditions appeared to be ~93% fast migrating single band 
representing the native RNA fold. These observations are consistent with the 
expectation that heat annealing cannot adequately guide RNAs across their rugged 
free energy folding landscape towards the native states.
26
 Rather native purification 
methods are increasingly vital to perform meaningful RNA research in general, and 
specifically in in vitro RNA folding and structural RNA studies. Our work argues for 
caution in interpretating kinetic data involving RNA prepared using 
heat-denaturation-refolding protocols. It also provides an important framework for 




Chapter 3: Conclusions and future work – Native RNA 
preperation 
 The first part of this dissertation connected the development of chemical tools to 
solve an important problem in RNA structural biology, which is how to circumvent 
the denaturing process in RNA preparation to avoid the adverse effect on function 
caused by misfolding during the refolding process? Using this method, we 
demonstrated that the RNA ‘folding/misfolding problem’ encountered by many 
researchers, when preparing RNA for biological studies, is more serious than 
originally thought.
38
 The traditional enzymatic method uses denaturing 
polyacrylamide gel electrophoresis (PAGE) purification with required cycles of 
denaturation and renaturation. Using that method, not only is it difficult to completely 
refold the denatured RNA into its native form, but it is also problematic to create a 
heterogeneous population of conformers.
23, 24
 However, our new RNA preparation 
method, using ‘click’ chemistry (Huisgen 1, 3-dipolar cycloaddition reaction) to 
couple biotin to a ‘caged’ photocleavable (PC) guanosine monophosphate (GMP) to 
synthesize RNAs, avoids the denaturing and refolding steps. The native RNA is easily 
washed off an avidin column after on-column photocleavage and elution under native 
preparation conditions. We successfully applied this method to transcribe RNAs 
ranging in size from 27 to 530 nucleotides, demonstrated that each of the RNA 
ribozymes D123 (493 nt) and D1235 (527 nt), which were prepared by our 
non-denaturing method, forms a homogenous population with higher catalytic activity 






 Although our method is easy and efficient for synthesizing native RNAs, the low 
yield of RNA (~17%) when primed with biotin-PC-GMP leads to large amounts of 
mixture of unlabeled and labeled RNA. To improve the yield of biotin-PC labeled 




PART II – Cyclic-di-GMP (c-di-GMP) riboswitch 
Chapter 4: Introduction to Part II 
4.1 The Importance of cyclic-di-GMP (c-di-GMP) in bacteria 
Bis-(3’-5’)-cyclic guanosine monophosphate (c-di-GMP) was first discovered in 
1987 by Moshe Benziman, who demonstrated that it allosterically activated the 
membrane bound cellulose synthase enzyme in Gluconoacetobacter xylinus.
67
 
However, it was not until a decade later that c-di-GMP was proven to be a ubiquitous 
second messenger in bacteria that regulates the transition between sessile and motile 
lifestyles by interfering with cell motility at a low concentration and promoting the 
expression of an adhesive matrix component and biofilm formation at a high 
concentration (Figure 4.1A)
68-71
. The importance of c-di-GMP in controlling 
bacterial pathogenesis is now universally accepted.
72-75
 Recent studies have indicated 
that c-di-GMP is not only associated with cell-cell communication, pilus assembly
69
, 
and biofilm formation, but also has essential role in virulence or acts as an effective 
immunomodulator.
74, 76
 The link between c-di-GMP and virulence was initially 
demonstrated in the pathogenic organism Vibrio cholerae.
75
 It was shown that the 
production of virulent cholera toxin, which is responsible for the massive and watery 
diarrhea produced during a cholera infection, was increased with low intracellular 
levels of c-di-GMP.
75
 Recently, the critical function of c-di-GMP in regulating 
virulence was also demonstrated in some other known human pathogens, including 
the causative agents of gastroenteritis
73






4.2 Biosynthesis and degradation of c-di-GMP 
The intracellular level of c-di-GMP in the bacterial cell is influenced by an 
enzymatic synthesis and degradation process. C-di-GMP is generated from two 
guanosine-5’-triphosphate (GTP) molecules by diguanylate cyclase (DGC) enzymes 
containing GGDEF (Gly-Gly-Asp-Glu-Phe) or GGEEF (Gly-Gly-Glu-Glu-Phe) 
domain and degraded selectively by two different phosphodiesterase (PDE) enzymes 
that contain either EAL (Glu-Ala-Leu) or HD-GYP (His-Asp-Gly-Tyr-Pro) amino 
acid domains (Figure 4.1B).
77, 78
 EAL domain PDEs cleave c-di-GMP into a linear 
dinucleotide (pGpG) intermediate and then further into two GMP molecules,
79
 
whereas HD-GYPs hydrolyze c-di-GMP directly into GMP in one step.
80
 
Interestingly, there are some hybrid proteins that contain both DGC and PDE 
domains within the same polypeptide.
69-71
 Based on genomic sequencing, it is shown 
that 50-70% of all GGDEF and EAL domain proteins contain an additional accessory 
domain that function as a sensor of environmental factor to produce an output.
81
 
These well-recognized regulatory motifs, such as phosphorylation receiver domains 
(REC)
82, 83
, gas sensor domains (haemerythrin)
84
, oxygen-redox potential sensor 
domains (PAS)
85
 and blue light sensor domains (BLUF)
86
 fuse to GGDEF or EAL 
domains to regulate the enzymatic activities of the PDEs and DGCs for further 
c-di-GMP concentration regulation. Herein, the fact that GGDEF, EAL and HD-GYP 
domains are widespread in bacteria suggests that c-di-GMP is utilized as a second 








Figure 4.1. (A) Phenotypes and processes controlled by c-di-GMP. High concentration levels 
of c-di-GMP promote sessility and biofilm formation via the production of adhesive 
extracellular matrix components. Low c-di-GMP levels promote motility, proteolysis and the 
production of virulence factors. (B) Synthesis and degradation of c-di-GMP. C-di-GMP is 
synthesized from GTP by diguanylate cyclases containing GGDEF domains and is degraded 
into GMP by phosphodiesterase domains, containing either EAL or HD-GYP domains. 
 
 
4.3 C-di-GMP effector – Protein 
As a second messenger, c-di-GMP relays external stimuli (i.e. the first message) 
received by cell-surface receptors of sensor domains to the related effectors within the 
cell. Different concentrations of c-di-GMP modulate cellular functions through 
binding to various receptors and controlling various downstream signaling 




domain proteins that do not have their own enzymatic activities but regulate other 
proteins via domain-domain or protein-protein interaction upon binding to 
c-di-GMP;
88
 2) Degenerate GGDEF and EAL proteins, which have no catalytic 
activity.
89-91
 These proteins often contain mutations in one or more of the conserved 
active site residues and therefore are no longer catalytically active (such as PopA 
from Caulobacter crescentus), but they still retain the ability to bind c-di-GMP.
92
 3) 
Proteins with enzymatic activity, and in which catalytic proficiency is increased upon 
binding to c-di-GMP, such as PleD of Pseudomonas aeruginosa;
93, 94
  and 4) 
Transcription factors or repressors, such as FleQ of Pseudomonas aeruginosa, which 
regulate gene expression upon c-di-GMP binding
95, 96
. Collectively, these receptor 





4.4 C-di-GMP effector – Riboswitch RNA  
In addition to the proteins that bind c-di-GMP, the high frequency of GGDEF 
and EAL domains in bacteria implies another network of pathways involving 
c-di-GMP in global cellular functions. In the past few years, this hypothesis was 
supported by the discovery of c-di-GMP-I and II class riboswitch receptors, reported 
by the Breaker group (Figure 4.2).
102, 103
 There are approximately 500 examples of 
class I
102
 and 45 examples of class II riboswitches
103
 that have been computationally 
identified in many different bacterial species. It is worth noting that some bacteria 
carry a very high number of c-di-GMP riboswitches.
102
 These riboswitches are 




to regulate cellular processes including motility, pilus formation, biofilm formation, 
virulence factor expression, and flagellum biosynthesis. The broad distribution of 
c-di-GMP binding riboswitches throughout the bacterial domain also indicates that 










Although over 20 different riboswitch classes, which recognize diverse ligands, 











, and even metals
109
 or small anions
110
, have been identified so far, 




messenger signaling molecule. It is a section of 5’ untranslated region (5’-UTR) 
mRNA in bacteria that contains two regions, an aptamer domain and an expression 
platform. The aptamer domain is responsible for recognizing and binding its target 
molecule – c-di-GMP, leading to a conformational change that alters the expression 
platform to regulate either transcription or translation (Scheme 4.1).
102, 103
 In 
translational control, the Shine-Dalgarno (SD) sequence (a ribosome binding site 
located eight base pairs upstream of the start codon in an mRNA) is either 
sequestered or exposed to modulate ribosome binding. In transcriptional systems, 
sequestration of the terminator or anti-terminator sequence controls transcription. 
However, the switches between ‘ON’ to increase expression levels of the downstream 
genes and ‘OFF’ to decrease the expression level are independent of whether the 
riboswitch controls transcription or translation. One example of c-di-GMP riboswitch 
operating at the transcriptional control level is the Cd1 class I riboswitch from 
Clostridium difficile. The transcription of mRNA is terminated in the presence of a 
higher concentration of c-di-GMP, decreasing flagellum biosynthesis and repressing 
motility.
102
 An example of c-di-GMP riboswitch using translational control is the Vc2 
riboswitch in Vibrio cholera. In the presence of c-di-GMP, Vc2 riboswitch RNA 
upregulates expression of the Vc1722 gene product.
102
 Additionally, there is also an 
example of gene expression regulation through intron self-splicing in the c-di-GMP 
class II riboswitch from Clostridium difficile 630. Its c-di-GMP aptamer resembles 
group I self-splicing ribozymes, in which two ligands GTP and c-di-GMP collaborate 
to promote self-splicing and function as a tandem riboswitch-ribozyme, initiating 
translation.
103




could check leaky splicing and serve as a backup mechanism to ensure translational 












As one class of c-di-GMP effector, c-di-GMP riboswitches have higher binding 
affinities than any known protein receptors, ranging from 10 pM
102, 113
 for the class I 
riboswitch to between 200 pM and 2 nM for the class II riboswitch
103
. For the Vc2 
RNA class I riboswitch from Vibrio choleae, it is known that the strong binding 













. However, such slow off-rate corresponds to a half-life of 
approximately 1 month, meaning that the ligand is effectively irreversibly bound in 
the biological timeframe. Therefore, class I riboswitches with tight binding affinity 
are likely controlled kinetically, in which gene regulation is determined by the 
competition of the on-rate with the rate of transcription. In the cell, the choice 
between ‘ON’ or ‘OFF’ must be made during transcription of the mRNA and binding 
must occur on a relevant time scale to regulate the downstream genes.
113
 Except for 
Vc2 RNA, the kinetic properties of other class I riboswitches and class II 
riboswitches have not been explored. 
  
4.5 Structure of class I and class II c-di-GMP riboswitch 
 To better understand the molecular basis of RNA recognition of c-di-GMP, the 
crystal structures of c-di-GMP bound to the aptamer domains of both class I and class 
II riboswitches have been determined.
113-115
 Due to the three-dimensional 
architectures of these two classes of riboswitches, each riboswitch provides specific 
binding pockets for c-di-GMP and has different modes of ligand recognition (Figure 
4.2). The class I bound form of the riboswitch consists of three helices that adopt a 
y-shape and c-di-GMP bound at the three helix junction
113, 115




bound form riboswitch folds into a more compact conformation containing three 




Figure 4.3. Active site architectures of class I (Vc2) and class II (CdA) riboswitches. 
Adenines in yellow are intercalated in both Vc2 and CdA. The blocks in green represent the 
stacking interactions above and below c-di-GMP. The direct interactions between 
nucleobases and c-di-GMP are shown in blue and magenta and the important hydrogen 
bonding interactions are shown in the details. 
 
 
 In the class I riboswitch, c-di-GMP binds at the junction of three helices, P1, P2 
and P3 (Figure 4.2, label with residue numbers to correspond). Two critical 
nucleotides (G20 and C92) specifically recognize the two guanine bases (Gα and Gβ) 
of c-di-GMP asymmetrically in canonical pairings. G20 contacts the Hoogsteen face 
of top base (Gα), while C92 N3 forms a canonical Watson-Crick pair with the bottom 
base (Gβ) N1 (Figure 4.3).
113, 115




mutational studies show that adenosine (A47) stacking between the two guanine 
bases is highly conserved.
116
 It intercalates between the two bases of c-di-GMP to 
bridge the P1 and P2 helices with the ligand through extensive stacking interactions. 
Furthermore, recognition of the ribosyl-phosphate backbone also plays an important 
role in c-di-GMP binding to the class I riboswitch. The recognition between the 
backbone of c-di-GMP and the riboswitch is mediated by both hydrogen bonding and 
metal-phosphate contacts, with one phosphate on c-di-GMP more heavily recognized 
than the other (Figure 4.4). 
 
Figure 4.4. C-di-GMP ribosyl-phosphate backbone recognized by the class I riboswitch. The 
atoms circled in green are recognized via hydrogen-bonding and metal-phosphate contacts at 





 Compared to the class I c-di-GMP riboswitch, the class II riboswitch also 
recognizes the two guanine bases of c-di-GMP asymmetrically, but the nature of this 
interactions is significantly different (Figure 4.3).
114
 Firstly, there is only one 
hydrogen-bonding interaction between the intercalating adenosine (A70) and a 
nonbridging phosphate oxygen on c-di-GMP in class I riboswitch opposite to the 
extensive backbone recognition of c-di-GMP by class I riboswitch. Secondly, there is 




recognized as part of the a base triple with A69 and U37 of class II riboswitch, and Gβ 
interacts with the A70 and G73 residues through hydrogen-bonding and hydrated 
magnesium. However, the only similar recognition to class I riboswitch is the 
stacking interactions between two guanine bases of the ligand and the RNA residues 
in the binding pocket. Three conserved adenosine nucleotides A61, A70 and A13 
stack above, between and below the two bases of c-di-GMP respectively. This base 
stacking is important for ligand binding.
117
 Based on these binding pocket structures 
of the bound forms of the class I and class II riboswitches, it is likely that the two 
riboswitches sense c-di-GMP via different mechanisms. 
 
4.6 Targeting c-di-GMP binding riboswitches with different c-di-GMP analogs 
 The prevalence of c-di-GMP in many human pathogens, in contrast to its absence 
in eukaryotes, makes c-di-GMP receptors attractive as new drug targets for the 
development of therapeutics against bacterial infection. Recently, there has been 
renewed interest in developing therapeutics against RNA targets. Along these lines, 
we have been interested in the development of c-di-GMP – like molecules (analogs) 
that could specifically bind to the pathogenic bacterial riboswitch in polymicrobial 
systems or bind to c-di-GMP riboswitches to cause biological processes that are 
different from those produced by the native c-di-GMP. 
 To achieve the above goal, it is important to understand how the structural features 
of the ligand are required for specific binding and to identify which moieties of the 
ligand are important for binding. Herein, structure-activity relationship (SAR) studies 




including base, ribosyl-phosphate modified analogs, have been investigated (Figure 
4.5 and Table 4.1).
117-120
 In addition, binding of c-di-GMP riboswitches to pGpG – 
the breakdown product of c-di-GMP, and the other linear analogs GpG and GpGp, 
has also been studied (Table 4.1).
118
 From these studies, it reveals that the class II 
riboswitch is tolerant to many c-di-GMP analogs, but the class I riboswitch is either 
completely discriminated against or bound with a significantly weaker binding 
affinity compared to the wild type ligand (Figure 4.5 and Table 4.1). Then the main 
binding difference could be further utilized as a strategy for manipulating specific 
biological activities under the control of the class II riboswitch without affecting 
processes regulated by the class I riboswitch. For example, both the Strobel group and 
our group have proven that bulky modifications at the 2’-OH position of the ribose 
rings, e.g. OMe and the addition of biotin (see Chapter 5) can be used to distinguish 
class I and II riboswitches
114, 119
. In addition, other analogs that showed a binding 
preference for the class II riboswitch over the class I riboswitch include c-di-IMP, 
c-di-dGMP and c-(RpSp)-di-Gps (Table 4.1). These observations underscore the point 
that the class II riboswitch is highly tolerant to modifications of the bases, 













Modification  Binding Affinity  (Kd)  
Wild Type C-di-GMP  -  Class I Vc2 RNA
a
: 1.4± 0.1 nM
117
  







G-GMP  A1 = CH  Class I Vc2 RNA
a
: 1100 ± 80 nM
117
 





GMP  A1 = CH,  
A2 = CH  







B1 = N-CH3  Class I Vc2 RNA
a
: 420 ± 16 nM
117
 





C-di-IMP C1 = inosine,  
C2 = inosine  










C1 = inosine  Class I Vc2 RNA
a






C-di-AMP C1 = adenine 
C2 = adenine  





C1 = adenine Class I Vc2 RNA
a
: 1600 ± 160 nM
117
  







C-dG-GMP D1 = H  Class I Vc2 RNA
a
: 51 ± 5.4 nM
117
 
C-di-dGMP  D1 = H,  
D2 = H  
Class I Vc2 RNA
a
: 2600 ± 88 nM
117
 





D1 = H  Class I Vc2 RNA
a





D1 = OMe,  
D2 = OMe  
Class I Vc2 RNA
a
:  ~ 30,000 nM
117
 





D1 = F,  
D2 = F  










E1 = S,  
E2 = S  










E1 = S,  
E2 = S  
Class I Vc2 RNA
a
: 150 ± 33 nM
117
  
Class II CdA RNA: 3.6 ± 0.6 nM
117
  
Wild Type C-di-GMP - Class I Vc2 RNA
b





GpG  Linear  Class I Vc2 RNA
b
: 210 ± 24 nM
118
 
pGpG  Linear  Class I Vc2 RNA
b
: 490 ± 150 nM
118
 
GpGp  Linear  Class I Vc2 RNA
b





Table 4.1. Binding affinities of c-di-GMP riboswitches with different c-di-GMP analogs. 
a
Class I Vc2 riboswitch used here is the G94(2AP) mutant. 
b
The class I Vc2 riboswitch 
measured here is the C92U mutant. 
 
 
 As described in Section 4.5, the only similarity between ligand recognition by 
the class I riboswitch and ligand recognition by the class II riboswitch is the base 




conserved binding pocket residues (Figure 4.3). Strobel et al. have demonstrated that 





4.1) to c-di-GMP riboswitch cost more binding energy than predicted due to deceased 
base pairing and stacking interactions.
117
 To further prove the importance of this base 
stacking interaction, our groups developed an endo-O modified analog 
endo-S-c-di-GMP (Figure 4.5F, modification of one of the endo-Os to S) to 
investigate the binding to two classes of riboswitches. Previously, we have proven 
that endo-S-c-di-GMP favors the ‘open’ or ‘trans’ conformation (the two guanines are 
on opposite sides) in solution rather than the ‘closed’ or ‘cis’ confirmation (the two 
guanines that are on the same side) and it is even three times less likely to populate 
the closed conformation than opened conformation.
121
 However, the ligand in two 
classes of c-di-GMP riboswitches must be bound in the closed conformation in order 
to maintain base stacking interactions within the binding pocket nucleotides. Based 
on these two factors, class I and class II riboswitches bind to endo-S-c-di-GMP much 




 Although there are extensive studies of different analogs binding to two classes 
of c-di-GMP riboswitches, no research on analogs used to specifically bind the 
subclass of each class of c-di-GMP riboswitch has been reported. Since there are 
approximately 500 examples of class I c-di-GMP riboswitches that have been 
computationally identified in a wide range of bacteria and most of them are found in 
multiple copies in pathogenic bacterial genomes,
113
 we have become more interested 




our next aim is to utilize different c-di-GMP analogs to discriminate the subclass 
RNAs in class I riboswitch (see Chapter 6). The future optimized analogs are 
potential chemical and therapeutic tools to study the mechanism of c-di-GMP 
riboswitch and inhibit the c-di-GMP pathway signaling in specific bacteria in 
polymicrobial systems.  
 
4.7 Dynamic conformational changes of the class I c-di-GMP riboswitch in response 
to Mg
2+
 and its ligand 
 In contrast to its regulator protein effectors, ligand binding to c-di-GMP 
riboswitches is directly coupled to gene regulation. Analysis of the X-ray structure of 
the bound form of the class I Vc2 riboswitch has prompted researchers to ask the 
question: How do ligands reach the deeply buried binding pocket and trigger a 
conformational change in the expression region to regulate the downstream gene? 
This interesting and important question has inspired investigation into the dynamic 
behavior of the riboswitches. It is known that the dynamic changes that occur in RNA 
structure serve a range of functions, such as regulation of gene expression and signal 
transduction.
111, 122, 123
 Previous studies of RNAs have shown that divalent cations 
induce tertiary interactions to cause the RNA to fold into compact structures. For 
example, Mg
2+
 ions often play a particularly important role in enabling the formation 
and functional stabilization of compact RNA structures.
124
 In addition, the high 
specificity and affinity of the riboswitch aptamer for its ligand is coupled to complex 






 To gain greater insight into the nature of secondary and tertiary structural 
rearrangement of the c-di-GMP riboswitch in the presence of Mg
2+ 
and ligand, 
different biochemical and biophysical tools have been used.
111, 126
 For example, 
small-angle X-ray scattering (SAXS), a powerful technique for determining global 
structural information of macromolecules, has been used to explore the folding of the 




  The 
angular range in SAXS contains information on the global shape of free and bound 
form of Vc2 riboswitch. Low-resolution molecular shapes calculated from the data 
suggest that in the absence of c-di-GMP, the Vc2 RNA adopts an extended 
conformation and then binding of c-di-GMP forms the compact conformation.
115
 This 
result is consistent with data from in-line probing experiments, which suggest that the 
P1 stem is unstructured under these conditions.
102
 Additionally, Wood et al. analyzed 
the interplay between Mg
2+
 ion, second-messenger ligand and tertiary interaction in 
the class I Vc2 riboswitch folding using single molecule fluorescence resonance 
energy transfer (smFRET).
127
 They further confirmed the extended and compact 
conformations of Vc2 RNA in the absence or in the presence of Mg
2+
 and the ligand 
(Figure 4.6) and revealed that the Vc2 aptamer domain is kinetically partitioned into 
different folded populations: extended, intermediate and compact.
127
 In the presence 
of Mg
2+
, the intermediate conformation is stabilized by the interaction of GNRA 
tetraloop (TL) in P2 and tetraloop receptor (TLR) in P3 and base pairing of C44:G83. 
Then this Mg
2+
-dependent dynamic population offers a preorganized structure that 
allows efficient ligand binding and conformational folding. The stabilization of the 







Figure 4.6. Proposed folding pathway of class I Vc2 riboswitch. Figure is adapted from 





 Although previous smFRET and SAXS studies of the Vc2 riboswitch have 
suggested a stepwise global rearrangement upon Mg
2+
 ion and c-di-GMP binding,
115, 
127
 the degree of compaction induced by Mg
2+
 ion or ligand binding can vary even 
between aptamer domains of the same riboswitch class. For instance, this has been 
seen in the thiamine-pyrophosphate (TPP) riboswitch from Escherichia coli and 
Arabidopsis thaliana.
128
 Thus, we are interested in investigating the conformational 
change and structural difference in our experimentally verified new class I riboswitch 
from Clostridium tetani E88 (Ct-E88) (see Chapter 7), especially given the large 
differences in binding affinities of c-di-GMP analogs versus the known class I Vc2 
RNA (Chapter 6). Different complementary biochemical and biophysical tools, 
including selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE) 
analysis to characterize the secondary structures, SAXS to monitor the global 
conformational changes, and nuclear magnetic resonance (NMR) spectroscopy to 
map the details of hydrogen-bonding at atomic levels, were used to investigate the 
details of how Mg
2+
 helps to set up the binding pocket from the extended 




such a study, we will better understand the mechanism of ligand recognition and how 









Recently, our lab and others have been interested in the synthesis of c-di-GMP 
analogs with the ultimate aim of using these analogs to control the biofilm phenotype 
via selective or differential modulation of c-di-GMP binding proteins and RNA.
121, 
129-132
 The majority of c-di-GMP binding proteins and RNAs have not been identified 
or are poorly characterized. Chemical tools, such as biotinylated c-di-GMP analogs, 
will therefore be useful for the identification of macromolecules that are involved in 
the c-di-GMP signaling cascade. It is however not known if the available 
2’-biotinylated analogs of c-di-GMP are appropriate tools for the identification of 
c-di-GMP binding riboswitches. We believe that it is timely for this issue to be 
addressed. In this chapter, we investigate how 2’-modification as well as conservative 
phosphate modification of c-di-GMP affects binding to two c-di-GMP riboswitches. 
We also describe a straightforward synthesis of phosphate and biotinylated analogs of 
c-di-GMP (compounds 2 and 3, Figure 5.1), using a simple solid phase methodology. 
Binding studies of c-di-GMP and analogs 2-4 (Figure 5.1) with class I and II 
c-di-GMP riboswitches reveal that the 2’-modification of c-di-GMP may affect 
binding to them, and hence caution has to be taken when using these capture probes 





5.2 Materials and Methods 
5.2.1 Materials 
2’-O-(6-[Biotinyl]aminohexylcarbamoyl) cyclic diguanosine monophosphate 
(2’-[Biotin]-AHC-c-diGMP) was purchased from Axxora. 
All concentrations of c-di-GMP and its analogs were determined by UV 




) at room temperature. 
 
5.2.2 Vc2 RNA preparation and purification 




5.2.3 C. acetobutylicum RNA preparation and purification 
CdA RNA was prepared and purified as described.
133 
 
5.2.4 Microdialysis assay of Vc2 / CdA RNA with c-di-GMP and analogs 
The equilibrium microdialysis assay was carried out in a 2×25 μl chamber 
(Harvard Apparatus) separated by a 10,000 Da cut-off regenerated cellulose 
membrane (Harvard Apparatus). Buffer I was used for the assay: 10 mM sodium 
cacodylate (pH 6.8), 20 mM KCl and 5 mM MgCl2. 25 μl of ligand and 25 μl of RNA 
(25 μM) were added to chambers A and B respectively. The microdialysis setup was 





5.2.5 UV260nm measurement of c-di-GMP in chamber A after microdialysis 
To obtain UV260nm readings, the content of chamber A (25 μL) was transferred to 
a 1 cm path length cuvette and the absorbance at 260 nm taken, using a JASCO 
V-630 spectrophotometer. 
 
5.2.6 Molecular Modeling 
All dockings were performed as blind dockings (blind docking refers to the use 
of a grid box which is large enough to encompass the ligand in the binding pocket) 
using Autodock Vina 1.1.1.
134
 
 Autodock Vina docking was performed using an exhaustiveness value of 64. All 
other parameters were used as defaults. All rotatable bonds within the ligand were 
allowed to flexibly rotate, and the receptor was considered rigid. The bound 
c-di-GMP and water molecules were first removed from the binding site of the RNA 
and the analogs were docked onto this site. All ligand structures were created using 
GaussView 03W software and then brought to their energetically minimized 
conformers by the Gaussian 03W program utilizing optimization=modredundant 
hf/6-31g(d) method
135
 with different fixed distance between C5’-C5’ on two guanines 
in the ligand. Polar hydrogens were added to ligand and RNA atoms. Autodock Tools 
version 1.5.4
134
 was used to convert the ligand and RNA receptor to the proper file 
formats for Autodock Vina docking. For each compound (Figure 5.1), only the 
docked structure with the largest binding affinity was assumed to be the predicted 





Figure 5.1. C-di-GMP and analogs. (1) c-di-GMP. (2) endo-S-c-di-GMP. (3) 
2’-[Biotin]-endo-S-c-di-GMP. (4) 2’-[Biotin]-AHC-c-di-GMP (commercially available). 
 
 
5.3 Results and Discussion 
The attachment of a biotin moiety to biological molecules and the use of the 
biotinylated analogs to identify binding partners are not new in biological studies. 
However, a critical issue that needs to be addressed when attaching a biotin moiety to 
any molecule of interest is to determine which site on the molecule can be modified 
with the biotin fragment without abrogating the binding of the molecule of interest to 




interest exists in generating biotinylated analogs of c-di-GMP and the use of these 
analogs to capture c-di-GMP proteins via affinity chromatography. So far, there is 
one reported synthesis of biotinylated c-di-GMP, which required eleven steps.
132
 In 
that report, the authors appended the biotin moiety at the 2’-OH position via a click 
reaction of 2’-alkyne analog of c-di-GMP and biotin azide.
136
 We readily prepared 
biotinylated c-di-GMP containing a bridging sulfur (refer to as 
2’-[biotin]-endo-S-c-di-GMP (3), Figure 5.1C) following reported solid-phase 
methodology
137
 followed by a click reaction with biotin azide (Figure 5.2). 
2’-[Biotin]-AHC-c-di-GMP (4), which contains natural phosphodiester moiety, is 
commercially available (albeit expensive) and was purchased from Axxora, LLC for 
this study. We reasoned that investigations into the binding of these c-di-GMP 
analogs would reveal whether the 2’-position of c-di-GMP could be modified with 
biotin without affecting binding to c-di-GMP binding macromolecules. For this study, 














5.3.1 Docking of c-di-GMP and analogs into RNAs 
We first used computational methods to investigate the interaction of c-di-GMP 
and analogs (1-4) with c-di-GMP class I riboswitch Vc2 RNA (c-di-GMP binds 
tightly to it with Kd = 10 pM). Autodock has been reliably used to study small 
ligand-nucleic acid interactions
138
 and we decided to use AutoDock Vina for our 
docking study. C-di-GMP can adopt conformations spanning cis and trans isomers. In 
the cis conformation, the two guanines are on the same side whereas in the trans 
conformation, the two guanines are on opposite sides (Figure 5.3A).  
Using the Gaussian program, we fixed the distance between the two guanine 
nucleobases of c-di-GMP or analogs (C5 of the guanines) at different values (between 
5.5 to 9.5 Å; Appendix 4) and determined their ground state conformations. To save 
computational time, simpler 2’-modified analogs of c-di-GMP, (5) and (6) (Figure 
5.3B), were used to model the binding of 2’-[Biotin]-endo-S-c-di-GMP (3) and 
2’-[Biotin]-AHC-c-di-GMP (4) in Figure 5.1 to Vc2 RNA. Figure 5.3C shows a plot 
of binding energy versus distance between the two guanines of c-di-GMP, for the 
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docked into Vc2 RNA
 
Figure 5.3. (A) The distance between C5 of the two guanines of c-di-GMP were fixed at 
distances ranging from 5.5 Å to 9.5 Å and the different conformers were optimized using 
Gaussian. (B) Structures of compounds 5 and 6 used as a model for biotinylated analogs 3 
and 4. (C) Plots of binding energies versus distance between the two guanine nucleobases of 
c-di-GMP, endo-S-c-di-GMP, compound 5 or compound 6 after docking into Vc2 RNA 
(PDB: 3IRW). Dockings were done in triplicate for each c-di-GMP or analog conformer. 
 
 
Interestingly, the c-di-GMP conformer that docks best to Vc2 RNA has the two 
guanine bases separated by 6.99 Å, which is remarkably close to the distance found in 




3IRW). Our docking study reveals that modification to the phosphate moiety of 
c-di-GMP affects binding to Vc2 RNA (the best docked conformer of c-di-GMP has a 
binding energy of -17.5 kcal/mol whereas that of endo-S-c-di-GMP is -14.0 kcal/mol). 
At 25°C, these free energies of binding translate into 368 folds tighter binding of the 



















Figure 5.4. Docking of c-di-GMP and endo-S-c-di-GMP in Vc2 RNA. (A) c-di-GMP 
docked into Vc2 RNA (PDB ID: 3IRW). The interactions in the docked structure are identical 
to those found in crystal structure of c-di-GMP bound to Vc2
113, 116
. C-di-GMP is colored 
yellow and the RNA nucleobases are colored yellow. (B) Endo-S-c-di-GMP (colored blue) 
docked into Vc2 RNA; (C) Overlay of c-di-GMP and endo-S-c-di-GMP docked into Vc2 
RNA. Gβ of endo-S-c-di-GMP can not form Watson-Crick hydrogen bonding interactions 
with C92 of Vc2 RNA. 
 
 
C-di-GMP makes three important interactions in the binding pocket of Vc2 RNA: 
Hoogsteen hydrogen bonding interactions between the Gα of c-di-GMP and G20 of 
the RNA aptamer; a Watson-Crick hydrogen bonding interactions beween Gβ and 
C92 of Vc2 RNA; and a stacking interaction between A47 of the RNA and the two 
guanines of c-di-GMP (Figure 5.4A).
116
 Endo-S-c-di-GMP maintains the interactions 
between the ligand’s Gα with G20 of the RNA as well as the stacking interaction of 
A47 and the guanine nucleobase of the cyclic dinucleotide but not the hydrogen 
bonding interactions between the Gβ and C92 of Vc2 RNA (Figure 5.4B). It appears 




c-di-GMP with sulfur affects the relative orientation of the two guanine nucleobases, 
resulting in the inability of one of the guanine bases in endo-S-c-di-GMP to form an 
essential hydrogen bonding interactions with C92 of the c-di-GMP riboswitch-I 
aptamer (Figure 5.4C). Endo-S-c-di-GMP is a very close analog of c-di-GMP and 
can be considered as one of the most conservative modifications of c-di-GMP, 
therefore our docking results suggest that c-di-GMP riboswitch-I aptamer is very 




Figure 5.5. C-di-GMP in the binding pocket of Vc2 RNA (PDB: 3IRW). (A) c-di-GMP is 
shown in stick and colored by atom (oxygen in red, nitrogen in blue, carbon in yellow and the 
2’-OH is colored green). Vc2 RNA is shown as mesh surface and colored by atom (oxygen in 
red, nitrogen in blue and carbon in light blue). (B) Zoom in of c-di-GMP in the binding 
pocket of Vc2 RNA. The green sphere, placed at the 2’-OH position, depicts how groups that 
are attached to this site in c-di-GMP would sterically clash with residues of Vc2 RNA. 
 
 
Our docking results also reveal that the modification of the 2’-OH of c-di-GMP 
completely abrogates binding to Vc2 RNA (compare docking results of compounds 
(1) and (2) in Figure 5.1 with (5) and (6) respectively in Figure 5.3).  We 
rationalize that, in the docked structure of 2’-OH-modified analogs of c-di-GMP, 
groups that are attached to the 2’-position of c-di-GMP (shown as green sphere in 
Figure 5.5B) would have a steric clash with some of the residues of the Vc2 RNA. It 




inappropriate sites to attach a biotin moiety. These computational studies revealed 
that the biotinylation of c-di-GMP could potentially render certain analogs ineffective 
at binding c-di-GMP class I riboswitch. 
We next proceeded to dock c-di-GMP into binding receptor c-di-GMP class II 
riboswitch C. acetobutylicum RNA (CdA RNA, PDB: 3Q3Z)
114
 (Appendix 5). For 
c-di-GMP class II riboswitch, only c-di-GMP (1) but not endo-S-c-di-GMP (2) or 
compound (5) or compound (6) displayed significant affinity for it. For c-di-GMP, 
our docking study reproduced experimental observations; the binding affinity of 
c-di-GMP is higher for binding to Vc2 RNA, compared to CdA RNA (compare 
Figure 5.3C to Figure 5.6). This is in agreement with previous work; which reported 
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docked into CdA RNA
 
Figure 5.6. Plots of binding energies versus distance between the two guanine nucleobases 
(after docking) of c-di-GMP, endo-S-c-di-GMP, compound 5 or compound 6 when docked 






5.3.2 Experimental validation of the docking results 
 Having predicted, via docking studies, that modifications to the phosphate or 
2’-OH positions of c-di-GMP would reduce binding to Vc2 RNA (a c-di-GMP class I 
riboswitch that binds monomeric c-di-GMP) and CdA RNA (a c-di-GMP class II 
riboswitch that binds monomeric c-di-GMP), we proceeded to test this experimentally. 
Equilibrium dialysis is an established method that is used for investigating binding of 
ligands to proteins and nucleic acids.
139
 The binding of c-di-GMP or its analogs to 
Vc2 RNA were directly measured qualitatively by equilibrium dialysis, as shown in 
Figure 5.7A. C-di-GMP was introduced into the two chambers of a micro 
equilibrium dialyzer (Harvard Apparatus) that has two 25 μl chambers (A and B), 
separated by a membrane with a cutoff molecular weight of 10 kDa (Figure 5.7A). 
Different amounts of Vc2 RNA were then added to chamber B of the micro dialyzer 
and the set up was agitated at 4˚C to reach equilibrium (24 h). Then the concentration 
of c-di-GMP or analog in chamber A was measured by UV absorbance at 260 nm 
(UV260nm). In the absence of c-di-GMP or analog binding to the RNA that was 
introduced in chamber B, the concentration of c-di-GMP in chamber A before and 
after the introduction of RNA into chamber B should remain constant. However, if 
c-di-GMP or analogs bind to the RNA that was introduced into chamber B, then the 
concentration of c-di-GMP in chamber A would decrease as more RNA was added to 
chamber B. Therefore a plot of the UV absorbance of a sample taken from chamber A 
at 260 nm versus the concentration of RNA that is added to chamber B (or the 
RNA:c-di-GMP ratio, Figure 5.7B) should give a qualitative information of the 




docking results, c-di-GMP bound to Vc2 RNA best, followed by endo-S-c-di-GMP. 
Neither 2’-[Biotin]-endo-S-c-di-GMP nor 2’-[Biotin]-AHC-c-di-GMP bind to Vc2 

















































Figure 5.7. Equilibrium microdialysis of c-di-GMP and analogs with Vc2 RNA. (A) 
Schematic diagram for equilibrium microdialysis. Reading 1 is the UV260nm measurement of 
ligand in chamber A when no RNA was added to chamber B and reading 2 is the UV260nm 
measurement of ligand in chamber A when different concentrations of Vc2 RNA were added 
to chamber B and allowed to be reach equilibrium after 24 h incubation at 4˚C. (B) A plot of 
the concentration of c-di-GMP or analogs in chamber A (measured as UV absorption at 260 
nm) versus the amount of RNA added in chamber A (denoted as RNA:ligand ratio). Error 
bars are generated based on standard deviation between three experiment repeats. 
 
 
We also performed equilibrium microdialysis of c-di-GMP and analogs with 
CdA RNA, see Figure 5.8. Some interesting trends emerge from the binding studies: 
CdA RNA (a class II riboswitch) is more sensitive to phosphate modification on 
c-di-GMP than Vc2 RNA (a class I riboswitch) but the reverse is true for 2’-OH 







Figure 5.8. Equilibrium microdialysis of c-di-GMP and analogs with CdA RNA. 
Experimental conditions and analysis were same as Figure 5.7. 
 
 
The origin of the different sensitivities of c-di-GMP riboswitch I and II towards 
2’-modification has already been discussed by two excellent papers by the Strobel 
group.
114, 117
 In riboswitch I, the two 2’-OH groups are close to RNA groups and the 
placement of groups at these positions would cause unfavourable steric interactions 
(Figure 5.5B). In riboswitch II, the two 2’-OH groups do not make as intimate 
contact with the RNA receptors, as is the case in riboswitch I, so therefore there is 
room for groups to be appended to this 2’-position (Figure 5.9).  Thus, it makes 
sense that biotin substitution of c-di-GMP at the 2’-position does not cause as much 
disruption to binding to riboswitch class II as it does to class I. The differential 
binding of the endo-S analogue (2) to class I and II is however surprising because 
both riboswitches make similar interactions with the phosphate moiety of c-di-GMP. 
In class I riboswitch, A47 of the RNA contacts the exocyclic and not the endocyclic 
oxygen of one of the phosphate groups in c-di-GMP whereas in class II, this contact 




would be little to no difference between the binding propensities of the endo-S 
analogs to both class I and class II riboswitches. We have however showed that small 
changes to c-di-GMP phosphodiester backbone (a thiophosphoroester modification to 
the bridging oxygen) can perturb the structure of the entire molecule (conformational 
steering).
121
 Plausibly, the endocyclic oxygen-to-sulfur modification at the bridging 
position in the phosphodiester linkage caused a perturbation that was more 
detrimental to the various binding interactions of c-di-GMP and RNA in class II than 
class I.  
 
 
Figure 5.9. C-di-GMP in the binding pocket of CdA RNA (PDB: 3Q3Z). Where 
c-di-GMP is shown in stick and colored by atom (oxygen in red, nitrogen in blue, carbon in 
yellow and the 2’-OH is colored green); CdA RNA is shown as mesh surface and colored by 
atom (oxygen in red, nitrogen in blue and carbon in light blue).The green sphere, placed at 





C-di-GMP was discovered more than two decades ago by Benziman and 






 It took close to twenty years after that discovery to appreciate that 
c-di-GMP regulates several processes that lead to biofilm formation in bacteria. 
Several groups have contributed to the understanding of c-di-GMP metabolism by 
identifying and biochemically characterizing the enzymes that make and degrade 
c-di-GMP (DGC and PDE respectively). In order to identify c-di-GMP riboswitches, 
with the ultimate aim of mapping the c-di-GMP interaction with RNAs to better 
understand global regulation of biofilm formation in bacteria, it is imperative that 
chemical tools are developed to identify c-di-GMP binding RNAs. In this research, 
we reveal that the site of biotin attachment on c-di-GMP can seriously affect binding 
to a class I riboswitch but little effect on a class II riboswitch. Endo-S-c-di-GMP 
prefers the trans conformation to the cis conformation, so its binding to both class I 
and class II riboswitches is decreased due to less stable stacking interaction of the 
ligand with the binding pocket nucleotides. Furthermore, this work also calls for 
future studies aimed at finding alternative positions to affix affinity labels on 






Chapter 6: Selective binding of 2’-modified c-di-GMP to 
various class I riboswitches 
6.1 Introduction 
C-di-GMP functions as an important second messenger in bacteria. Recent 
studies have shown that many critical biological functions are controlled via 
c-di-GMP signalling, including exopolysaccharide synthesis, cellular motility, 
virulence and biofilm formation.
71
 Although c-di-GMP has been studied for more 
than two decades,
67
 it is only recently that some of the molecular details of the 
interactions of c-di-GMP with macromolecular targets have been uncovered. Until the 
recent discovery by Breaker and co-workers that c-di-GMP binds to RNA 
(riboswitches) to regulate gene expression and translation,
102
 it had largely been 
assumed that c-di-GMP only binds to effector proteins, such as transcription factors, 
to regulate bacterial physiology.
88, 90-96, 102
 The discovery of these c-di-GMP 
responsive riboswitches expands the role of RNA in the c-di-GMP signaling pathway. 
Thus, inhibiting these c-di-GMP riboswitches with small molecules could potentially 
lead to the inhibition of biofilm formation or virulence factor production in bacteria. 
Motivated by the potential promise of c-di-GMP riboswitch inhibitors, we and others 
have embarked on structure-activity-relationship (SAR) studies of c-di-GMP binding 
to riboswitches.
114, 117, 119, 120
 To this end, we demonstrated that a 2’-biotinylated 
analog of c-di-GMP could bind to a class II c-di-GMP riboswitch, CdA RNA from 
Clostridium acetobutylicum, but not a class I riboswitch, such as Vc2 RNA from 
Vibrio cholerae.
119








Given these previous promising results and the preponderance of C-di-GMP class 
I and class II
 
riboswitches, we are interested in the identification of small molecules 
that can discriminate between different c-di-GMP class I riboswitch. C-di-GMP class 
I riboswitch can be found in both symbiotic and pathogenic bacteria
113
 and therefore 
being able to discriminate between class I riboswitches, found in symbiotic and 
pathogenic bacteria, will be critical for the maintenance of natural microbiota during 
antibacterial therapy. However, the paucity of structural data for different c-di-GMP 
class I riboswitches makes it difficult to design selective binders of c-di-GMP class I 
riboswitches a priori. We therefore investigated the SAR of c-di-GMP binding to 
different class I riboswitch (Figure 6.1), using c-di-GMP analogs (see Figure 6.2 for 
structures of analogs) to determine if different c-di-GMP class I riboswitches use 





Figure 6.1. (A) Alignment of predicted c-di-GMP riboswitch sequences. The nucleotides 
indicated by blue arrows are the same nucleotides indicated in blue in the predicted structures. 




. (B) Predicted structures of the 
selected c-di-GMP-I riboswitch aptamers based on structure model of the c-di-GMP class I 
aptamer.
113
 Cytidine on P2 stem in blue and guanine on P3 stem in blue are expected to form 
an interhelical Watson-Crick base pairing in the ligand bound structure and adenosine in blue 




cytidine and guanosine indicated in the boxes are the two important nucleotides base pairing 
with the two bases of c-di-GMP. 
 
 
6.2 Materials and Methods 
6.2.1 Preparation of c-di-GMP class I Riboswitch Aptamer RNAs 
The aptamer sequences of Vc2 RNA, Ct-E88 RNA, Cb-17B RNA, Cb-E43 RNA 
and Cd-630 RNA were obtained from the Rfam database.
142
 For riboswitches that 
contained flexible loops on P3 longer than four nucleotides, this loop was changed to 
a UUCG tetraloop to facilitate an easy synthesis of the RNA. A pUC57 plasmid 
containing each target sequence, including T7 promoter sequence, was constructed by 




6.2.2 Microdialysis assay of RNA with ligand 
Microdialysis was used to qualitatively gain insights into the binding between the 
various c-di-GMP class I riboswitches and c-di-GMP or analogs. The microdialysis 
assay was carried out in two 25 μL chambers (HARVARD APPARATUS) separated 
by a 10,000 Da cut-off regenerated cellulose membrane (HARVARD APPARATUS). 
25 μL of ligand and 25 μL of RNA in the same buffer (20 mM KCl, 6 mM MgCl2, 
and 10 mM sodium cacodylate, pH 6.8) were added to chamber A and B respectively. 
Equilibration was assumed to have occurred after 24 h, having left the microdialysis 
apparatus at room temperature (with slight shaking). UV260nm readings of the 25 μL of 
c-di-GMP or analog in chamber A were taken after 24 h of equilibration, using 




6.2.3 Preparation of 
32
P-labeled c-di-GMP 
E. Coli BL21 (DE3) was used for production of WspR (D70E) from pVL791. 
The bacteria were grown at 30°C in Luria-Bertani (LB) medium with shaking. IPTG 
was added at OD600 nm = 0.6 and protein expression was induced for 6 h. The protein, 
which has a His-tag, was purified on a nickel resin and dialyzed into a 10 mM Tris, 
100 mM NaCl solution. α-
32





6.2.4 Kd measurements of c-di-GMP and analogs by gel-shift  
RNA was folded by heating to 70ºC and slow cooling in folding buffer (20 mM 
KCl, 6 mM MgCl2, and 10 mM sodium cacodylate, pH 6.8) in the presence of 50 pM 
of radiolabeled c-di-GMP. Binding reactions were incubated at room temperature 
(25ºC) until equilibrium was assumed to have been reached (24 h for different class I 
riboswitches). The dissociation constant (Kd) of c-di-GMP for each class I riboswitch 
was then determined using a gel-shift assay. Unbound c-di-GMP was separated from 
RNA/c-di-GMP complex using 10% native PAGE (100 mM Tris/HEPES pH 7.5, 0.1 
mM EDTA, 1 mM MgCl2) at 4 ºC. Gels were dried and scanned using a STORM 
phosphorimager (Molecular Dynamics). For each ligand concentration, the bands 
corresponding to free and bound c-di-GMP were boxed and quantitated using 
ImageQuant software (Molecular Dynamics). The fraction of bound c-di-GMP was 
calculated using Equation (1).  




Where FB = fraction of c-di-GMP bound; IB = intensity of bound c-di-GMP band; IB = 
intensity of free c-di-GMP band;  
  
Then all data was fit to the following Equation (2) to determine Kd values
143
: 
FB =  
─  
Equation (2) 
Where FB = fraction of c-di-GMP bound; [P32cdGMP] = concentration of α-
32
P- c-di-GMP, 
which is at 50 pM; Kd = dissociation constant of c-di-GMP for the riboswitch RNA; [RNA]tot 
= total concentration of riboswitch RNA. 
 
Competition experiments to determine the Kd values of analogues were 
performed as described above. In this case, P-32 c-di-GMP and unlabeled competitor 
analog were premixed in folding buffer before adding RNA to a final concentration of 
100 nM of RNA. RNA was heated to 70 ºC for 3 min and slowly cooled in the 
presence of both labeled and unlabeled ligand and incubated at room temperature for 
48-72 h before resolving free and bound c-di-GMP by 10% native PAGE. Then the 
fraction bound (FB) of labeled c-di-GMP was quantified and the Kd value of the 
unlabeled competitor analogue was determined from quadratic solution of the Lin and 
Riggs equation determined by Weeks and Crothers
144, 145
, Equation (3): 
FB =  
                                                    Equation (3) 
 
Where FB = fraction of c-di-GMP bound; FB∞ = fraction bound in the absence of c-di-GMP 
competitor; FB0 = fraction bound in the presence of c-di-GMP competitor; [P32cdGMP] = 
concentration of P-32 labeled c-di-GMP, which is at 50 pM; Kd
cdGMP




of c-di-GMP for the riboswitch RNA; [analog] = concentration of unlabeled competitor 
analog; [RNA]tot = total concentration of riboswitch RNA; Kd
analog
 = dissociation constant of 
competitor analog. 
 
The binding energy (ΔGbind) of c-di-GMP or its analog was calculated from the 
following equation: 
ΔGbind = RTlnKd  Equation (4) 






) and T = temperature (295K). 
 
The change in binding energy (ΔΔGbind) was determined according to 
ΔΔGbind =ΔGbind (analog) – ΔGbind (c-di-GMP)  Equation (5) 
 
6.3 Results and Discussion 
Although over 500 examples of c-di-GMP-I class riboswitch RNAs have been 
predicted computationally,
113
 only two have been experimentally verified to bind to 
c-di-GMP. We selected four c-di-GMP-I class riboswitch aptamer candidates (Ct-E88, 
Cb-17B, Cb-E43 and Cd630 RNAs) from GEMM motif in Rfam database (Figure 
6.1).
142
 These putative c-di-GMP riboswitches are found in different pathogenic 





 (Cb-17B and Cb-E43) and Clostridium difficile
148
 (Cd-630). 
Vc2 RNA, from Vibrio cholerae, which has been biochemically and structurally 




C-di-GMP-I class riboswitch aptamers are predicted to form a three-helix 




P3. The crystal structure of Vc2/c-di-GMP complex reveals that 5’- and 3’- flanking 
nucleotides extended the putative P1 helix, to include a Waston-Crick G:C base pair 
between C92 residue of the RNA (boxed red in Vc2 model, Figure. 6.1B) and one of 
two guanosines of c-di-GMP (Gβ). Helices P2 and P3 are parallel to each other in the 
presence of Mg
2+
, while helix P1 only forms when c-di-GMP is present.
127
 Residue 
G20 (boxed green in Vc2 model, Figure 6.1B) in helix P2 of Vc2 contacts the top 
nucleobase of c-di-GMP (Gα) along its Hoogsteen face in the bound form. The highly 
conserved adenosine A47 (shown in boxed blue in Figure 6.1B) intercalates between 
the two nucleobases of c-di-GMP, resulting in extensive stacking interactions that 
bridge the P1 and P2 helices. Several nucleotides are conserved in the selected class I 
aptamers (Figure 6.1A) and the predicted structures of the selected riboswitches are 
similar, so we would expect that they all bind to c-di-GMP.  
 
6.3.1 Experimental validation of selected class-I RNA aptamer binding to 
c-di-GMP  
 To verify if the predicted class I riboswitches could bind to c-di-GMP, 
equilibrium microdialysis experiment was performed for each RNA (Vc2, Cd630, 
Cb-17B, Ct-E88 and Cb-E43) with different ligands. Equilibrium dialysis is a simple 
but effective assay to quickly and qualitatively determine if a ligand binds to a 
macromolecular target.
117, 119
 One of the advantages of the equilibrium dialysis assay 
is that sampling is done at equilibrium so it is possible to detect even the low affinity 
interactions that are difficult to detect using non-equilibrium methods, such as gel 




measured qualitatively by this method as described previously.
119
 A plot of UV260nm 
of ligand in chamber A versus the concentration of RNA in chamber B measures the 
relative binding affinities of selected c-di-GMP class I with c-di-GMP (Figure 6.3B). 
The equilibrium dialysis results showed that c-di-GMP could bind to Cb-E43, Ct-E88 
and Vc2 RNAs with similar affinities, whereas Cb-17B and Cd-630 RNAs had 
relative low binding affinities to c-di-GMP (Figure 6.3). We postulate that the low 
binding affinity of Cd-630 or Cb-17B RNA with c-di-GMP is likely due to the lack of 
a P1 helix in these two RNAs (Figure 6.1). Our microdialysis data suggests that 
Cb-E43 and Ct-E88 are likely to be functional c-di-GMP riboswitches in Clostridium 
tetani (Ct-E88) and Clostridium botulinum (Cb-E43).   
 
6.3.2 Recognition of 2’-position modified c-di-GMP analog 
Having identified Ct-E88 and E43 as potential functional c-di-GMP riboswitches, 
we next sought to investigate further their binding modes. Previous reports had 
demonstrated that modification of the 2’-position of c-di-GMP differentially affected 
binding to different classes of c-di-GMP riboswitches. The X-ray crystal structure of 
c-di-GMP/Vc2 complex indicated that one of the 2’-OH of c-di-GMP interacts with a 
nonbridging phosphate oxygen of A47 of Vc2 and this might partly explain why 
c-di-GMP class I riboswitches are sensitive to 2’-modification of c-di-GMP.
114, 117, 119
   
However, different c-di-GMP class I riboswitches have different residues in the 
predicted ligand binding pocket. Thus we hypothesized that discrimination between 
these riboswitches, which belong to the same class, could be achieved with c-di-GMP 




both, at the 2’-position. To test this hypothesis, we synthesized three different 
c-di-GMP analogs with the 2’-position modified, including 2’-F-c-di-GMP (2), 
2’-H-c-di-GMP (3) and 2’-OMe-c-di-GMP (4) (Figure 6.2) and investigated the 
binding affinities of these analogs for different c-di-GMP class I aptamers (Vc2, 
Cd630, Cb-17B, Ct-E88 and Cb-E43) using microdialysis. 
 
Figure 6.2. Family of c-di-GMP analogs designed and synthesized. 
 
 
Our microdialysis assay (Figure 6.3) indicates that c-di-GMP binds to Vc2, 
Ct-E88 and Cb-E43 RNAs with similar affinities, but these RNAs bind to different 
c-di-GMP analogs with different affinities. For example, it appears that Vc2 and 
Cb-E43 bind to 2’-F-c-di-GMP better than Ct-E88 (Figure 6.4A). Cb-E43 also binds 
to 2’-H-c-di-GMP slightly better than the other RNAs (Vc2, Ct-E88, Cd630 and 
Cb-17b, see Figure 6.4B). All of the tested c-di-GMP class I riboswitches are 
sensitive to steric encumbrance at the 2’-position because none of the RNAs bind to 







Figure 6.3. Equilibrium Microdialysis of selected c-di-GMP class I riboswitch aptamer with 
ligand. (A) Schematic diagram for equilibrium microdialysis. (B) A plot of the concentration 
of c-di-GMP in chamber A versus the amount of different c-di-GMP class I riboswitch 
aptamer added in chamber B. Error bars are generated based on standard deviation between 








Figure 6.4. Equilibrium microdialysis of c-di-GMP analogs. (A) 2’-F-c-di-GMP, (B) 
2’-H-c-di-GMP and (C) 2’-OMe-c-di-GMP with various class I riboswitch aptamers. 
 
 
 Strobel et al. have suggested that the deleterious effects of 2’-deoxy or 
2’-methoxy modifications are probably due to their inability to maintain a favored 
3’-endo conformation.
117




conformation, and this might explain why this particular analog, but not the deoxy or 
methoxy analogs, binds to Vc2, Ct-E88 and Cb-E43 RNAs. 
Future structural studies should help delineate the factors that contribute to the 
differential binding of c-di-GMP and analogs to these tested RNAs. Our biochemical 
data suggests that although the c-di-GMP class I riboswitches use some common 
binding determinants (such sensitivity to steric bulk at 2’-position), there are 
unexpected differences in the binding modes with c-di-GMP and these differences 
could be utilized for the development of selective small molecules that disrupt 
c-di-GMP signaling in some bacteria and not others. 
 
6.3.3 Affinity measurements of c-di-GMP and analogs for different class I 
aptamer 
Although the microdialysis assay provided a qualitative ordering of 
c-di-GMP/analog binding to the tested RNAs, to obtain quantitative binding constants 
required electrophoretic mobility shift assay (EMSA). We therefore used gel-shift 
assay to determine the Kd for c-di-GMP and the various class I riboswitches. The 
binding affinity of various class I riboswitch aptamer to c-di-GMP was measured by 
titrating a radiolabeled c-di-GMP probe with increasing concentration of RNA. The 
fraction of radiolabeled c-di-GMP that was bound was determined from the gel shift 
(Figure 6.5) and the data was fitted to a quadratic Equation (2) (see Materials and 





Figure 6.5. Kd measurement of c-di-GMP by gel-shift assay, using radiolabeled c-di-GMP. 
(A) Representative gel-shift experiment for measuring the Kd of c-di-GMP with Vc2 RNA by 
direct binding. (B) Representative c-di-GMP binding curve for class I aptamer RNA. (C) 
Gel-shift experiments for measuring the dissociation constants (Kd) of c-di-GMP with class I 
aptamers (Ct-E88, Cb-E43, Cb-17B and Cd-630 RNA). (See Appendix 6 for each binding 
curve fitting data) 
 
 





c-di-GMP 47.2 ± 3.7   
2’-F-c-di-GMP 176.0 ± 6.7 0.8 3.7 




2’-OMe-c-di-GMP > 1 mM > 5.8 > 21,000 
Ct-E88 
c-di-GMP 60.3 ± 5.3   
2’-F-c-di-GMP 44700 ± 9410 3.9 741 
2’-H-c-di-GMP 52130 ± 5720 4.0 863 
2’-OMe-c-di-GMP n.b.
a
   
Cb-E43 
c-di-GMP 128.3 ± 18.0   
2’-F-c-di-GMP 996.0 ± 10.1 1.2 7.7 
2’-H-c-di-GMP 12200 ± 6200 2.6 95.3 
2’-OMe-c-di-GMP n.b.
a
   
Cb-17B c-di-GMP > 1 μM   
Cd-630 c-di-GMP > 1 μM   
 
Table 6.1. Binding affinities of c-di-GMP and analogs for five class I riboswitches: Vc2, 
Ct-E88, Cb-E43, Cb-17B and Cd-630 RNAs.
 a
No detectable binding at highest ligand 
concentration (600 μM) tested. 
 
 
In agreement with the equilibrium microdialysis results, c-di-GMP bound to Vc2, 
Cb-43 and Ct-E88 RNAs tightly with nanomolar Kd values (Table 6.1), whereas no 
binding was observed for Cb-17B and Cd-630 RNAs, even at ligand concentrations 
of 1 μM or more. To measure the affinities of the unlabeled c-di-GMP analogs, a 
competition gel-shift assay with radiolabeled c-di-GMP was used since the 
preparation of radiolabeled c-di-GMP analogs is non-trivial. Class I aptamer and 
labeled c-di-GMP were incubated in the presence of increasing concentrations of the 
unlabeled competitor analogs until equilibrium was achieved. The fraction of free 








Figure 6.6. Kd measurement of c-di-GMP analogs using competition gel-shift assay with 
radiolabeled c-di-GMP. (A) Representative competition gel-shift experiment of Vc2 RNA 
with 2’-H-c-di-GMP. (B) Representative binding curve from the competition gel-shift assay. 
(C) Gel-shift experiments for measuring the Kd of 2’-H-c-di-GMP and 2’-F-c-di-GMP for 
each class I aptamer (Vc2, Ct-E88, Cb-E43 RNA) by competition assay. RNA, radiolabeled 




temperature until equilibrium. Free P-32 c-di-GMP is separated from RNA-bound c-di-GMP 
by 10% native PAGE. (See Appendix 6 for each binding curve fitting data) 
 
 
  Our data suggests that deletion of the 2’-OH group in c-di-GMP to give the 
2’-H-c-di-GMP was detrimental for class I riboswitch binding. The loss in binding 
energy was highest for Ct-E88 RNA (4.0 kcal/mol loss in binding energy), compared 
to Vc2 and Cb-E43 RNA (loss of 3.0 kcal/mol and 2.6 kcal/mol binding energies 
respectively). The loss in binding energy seen with 2’-H-c-di-GMP could be due to an 
abrogation of hydrogen bonding interactions between the RNA and c-di-GMP. 
Alternatively, it is also possible that replacing the 2’-OH group with hydrogen affects 
the ribose puckering, which then affects the relative orientation of the different 
moieties, including the nucleobases of c-di-GMP, to offset important interactions 
between c-di-GMP and RNA. To differentiate the sugar pucker effect from hydrogen 
bonding effect in c-di-GMP binding to these RNAs, the binding affinities of 
2’-F-c-di-GMP to Vc2, Ct-E88 and Cb-E43 RNAs were measured. The fluoro group 
is a good isostere for the OH group and it has been demonstrated that 2’-fluoro 
nucleotides also exist in the 3’-endo sugar puckering mode.
149
 Although Fluorine is 
more electronegative than oxygen, when bonded to carbon, fluorine is not as good a 
hydrogen bond acceptor as oxygen is.
150
 Secondly, the OH group can act as a donor 
or acceptor of hydrogen bond whereas the fluoro group can only accept a hydrogen 
bond. The loss in binding energy when the 2’- OH in c-di-GMP was replaced with a 
fluoro group was 3.9 kcal/mol for Ct-E88 RNA, resulting in 741-fold loss in binding 
affinity compared to c-di-GMP. Interestingly, the loss in binding affinity was only 




suggest that the hydrogen bonding interactions in the binding pocket of some class I 




We demonstrate that although c-di-GMP class I riboswitches have similar 
predicted folds, subtleties in the ligand binding pockets could allow for selective 
targeting of these riboswitches. The ability to selectively target one particular class I 
riboswitch, while not affecting others, could be used to affect c-di-GMP signalling in 
some pathogenic but not symbiotic bacteria. Although this dream remains to be 






Chapter 7: Conformations of C-di-GMP class I aptamer (Ct-E88 
RNA) – Preliminary data 
7.1 Introduction 
 In Chapter 6, we verified that a class I c-di-GMP riboswitch aptamer from 
Clostridium tetani E88 (Ct-E88) could bind c-di-GMP with nanomolar affinity and 
hence is likely to be a functional c-di-GMP riboswitch. It was found that Ct-E88 
RNA could bind c-di-GMP as tight as Vc2 RNA (the first c-di-GMP riboswitch to be 
identified). Interestingly, whereas both c-di-GMP and 2’-F-c-di-GMP could bind to 
Vc2 RNA with similar affinity, this was not the case with binding with Ct-E88. For 
Ct-E88 RNA, the binding affinity of c-di-GMP was close to three orders of 
magnitude tighter than 2’-F-c-di-GMP. This difference prompted us to ask the 
question of how Ct-E88 RNA recognizes the ligand differently from Vc2 RNA. The 
groups of Ferré-D-Amaré and Rueda have attempted to characterize ligand 
recognition and ligand-induced folding processes in the Vc2 riboswitch, using 
small-angle X-ray scattering (SAXS) and single-molecule fluorescence resonance 
energy transfer (smFRET). They have concluded that both Mg
2+
 cation and the 
c-di-GMP ligand are important for the proper folding of Vc2 riboswitch.
115, 127
 In 
their experiments, it was shown that the addition of Mg
2+
 or c-di-GMP or both caused 
significant conformational change in the RNA. We therefore wondered if the 
structure of Ct-E88 riboswitch is also modulated by Mg
2+
 ion, or ligand binding, or 
both.
151
 The conformational study of Ct-E88 RNA, in the presence of various analytes, 








  Based on the conservation of many residues between Ct-E88 and Vc2 RNAs, we 
hypothesized that Ct-E88 RNA would have a similar global structure to Vc2 and 
would also adopt multiple conformations, which are modulated by ions and c-di-GMP. 
However, because we also observed differences in binding to different analogs of 
c-di-GMP, especially significant difference in affinity for 2’-F-c-di-GMP, we also 
hypothesized that the binding pocket of Ct-E88 is likely different from that of Vc2 
RNA. To test these two hypotheses, different biochemical and biophysical tools, 
including native gel mobility shift assay, selective 2’-hydroxyl acylation analyzed by 
primer extension (SHAPE) technique, small-angle X-ray scattering (SAXS) analysis 
and NMR spectroscopy were used to gain some insights into how both cation and the 
nucleotide ligand affect the folding of Ct-E88.  
 
7.2 Materials and Methods 
7.2.1 RNA preparation 
The RNAs used in this study is the UUCG-tetraloop modification of P3 helix. 
The RNAs were transcribed and purified as described before.
152
 The crude RNA was 
purified using a 12% denaturing PAGE with 1×TBE buffer. The RNA pellet was 
dialyzed in a Biodialyzer (Nestgroup) with a 500 MWCO membrane (Nestgroup) for 
24 h against 100 mM potassium phosphate buffer (pH 6.4), 0.5 M KCl, 10 mM 
EDTA, and then 1 and 0,1 mM EDTA, and finally against two changes of double 






7.2.2 Electrophoretic mobility shift assay (EMSA) 
To explore the conformational change between Ct-E88 RNA free and bound 
form, EMSA was performed.
115
 RNA was folded by heating to 70ºC for 3 min and 
slow cooled in folding buffer (20 mM KCl, 6 mM MgCl2, and 10 mM sodium 
cacodylate, pH 6.8) in the presence of saturated ligand concentration (2 × 
concentration of RNA). The reaction mixtures were incubated at room temperature 
(25ºC) before separating on the gel. Electrophoresis was performed using native 
PAGE (10% acrylamide/bisacrylamide (19:1), 100 mM Tris/HEPES pH 7.5, 0.1 mM 
EDTA and 1 mM MgCl2) at 4 ºC. The gels were stained with ethidium bromide and 
images were scanned using STORM phosphoImager (GE Healthcare). 
 
7.2.3 Selective 2’-hydroxyl acylation analyzed by primer extension (SHAPE) 
To identify local changes of RNA structure and characterize the general 




 III First-Strand Synthesis System for RT-PCR kit was purchased 
from Invitrogen. T4 polynucleotide kinase was purchased from New England Biolabs. 
γ-[
32
P]-ATP was ordered from Perkin Elmer. The experiment procedures were 
adapted with little modification from Wilkinson et al.
153
 (Figure 7.1). 
RNA folding and modification 











Because SHAPE reactivities are assessed in a reverse transcription primer 
extension reaction, the 10-20 nucleotides adjacent to the primer binding site cannot 
to be read due to the presence of short cDNA fragments caused by pausing during 
the initiation phase of primer extension by the reverse transcriptase enzyme and the 
8-10 positions at the 5’-end of the RNA also cannot to be visualized due to the 
presence of the intense band corresponding to the full-length extension product.
153
 
Therefore, the interested Ct-E88 RNA can be embedded within a cassette (Figure 
7.1) that contains 5’ (red) and 3’ (blue) flanking sequences with a primer binding 
site (green) to allow all positions within the RNA of interest to be visualized in a 
sequencing gel. Both 5’ and 3’ linker extensions are designed to fold into stable 
hairpin structures that do not interfere with folding of the interested internal 
RNA.
154
 The sequences of the 5’ and 3’ linker were checked by MFold to ensure 
that they were not prone to form stable base pairing interaction with the Ct-E88 
RNA sequence.  




5’- GG CCU UCG GGC CAA UUU CCA CGA UAA AGG CAA AAC UAU 
UGA AAG AUA GUG ACG CAA AGC UAU AGG GUC UUC GGA CAG CCA 
GUU AUC GAA AGG AGA UCG AUC CGG UUC GCC GGA UCC AAA UCG 
GGC UUC GGU CCG GUU C -3‘ (138 nt) 
Where the nucleotides indicated in red are 5’-linker, nucleotides indicated in blue are 
3’linker and nucleotides in green are RT primer binding site. 
 
RNA was prepared and purified as previously described.
50
 
 1 pmol of RNA was folded in 9 μL of folding buffer containing 100 mM HEPES 
(pH 6.8) and 100 mM NaCl. To this was added either 3 mM MgCl2, or ligands, or 
both. Each mixture was incubated overnight at room temperature before adding 1 μL 
of N-methylisatoic anhydride (NMIA) (65 μM) or 1 μL of pure DMSO (labeled as (-) 
NMIA) as negative control. Then the reaction mixtures were incubated at 37 ºC for 45 
min. After the reaction had gone to completion, the modified RNAs were recovered 
by ethanol precipitation with 90 μL of water, 4 μL of 5 M NaCl, 1 μL of 20 mg/mL 
glycogen, 2 μL of 100 mM EDTA (pH 8.0) and 350 μL of absolute ethanol and 
incubated at -20ºC overnight.  
32
P-primer for reverse transcription 
50 pmol of RT binding oligo [5’- GAA CCG GAC GAC CGA AGC CCG -3’] (2 
μL of 25 pmol/μL) was mixed with 4 μL of 10 x T4 PNK buffer (New England 
Biolabs, cat. no. M0201S), 30 μCi of γ-[
32
P]-ATP (6 × 10
6
 Ci/mol, 10 Ci/L, Perkin 
Elmer cat. no. BLU502Z) and 0.5 μL of T4 polynucleotide kinase (New England 
Biolabs, cat. no. M0201S) in a total volume of 40 μL. The mixture was incubated at 
37ºC for 1 h before purification by G25 column (GE Healthcare). 
Primer extension and RNA sequencing 
RNA samples were redissolved in 8 μL of water and a 6 μL aliquot was added to 
the reaction mixture containing 4 μL of 
32




Primer annealing was carried out at 65ºC for 5 min, at 35ºC for 5 min and then on ice 
for 1 min. The reverse transcription reaction was then started using (-) NMIA and (+) 
NMIA samples, 3 μL of SuperScript III enzyme mix (0.25 μL of dNTP mix, 0.25 μL 
of 0.1 M DTT, 1 μL of 5x Superscript buffer, 0.25 μL of superscript III enzyme and 
1.25 μL of water) by adding it into 2 μL of RNA and primer mixture above. For the 
four sequencing samples (A/C/U/G), 2.9 μl of SuperScript III enzyme mix (same as 
above) was added into 1.9 μL of RNA (from DMSO control reaction) and primer 
mixture with 1 μL of each ddNTP respectively. All the samples were incubated at 52 
ºC for 20 min. Then 3 μl of formamide loading dye was added to each sample for a 
final volume of 8 μL and heated at 95 ºC for 5 min before loading on the 8% 
denaturing polyacrylamide (19:1 acrylamide: bis-acrylamide, 8 M urea) gel.  
 
7.2.4 Small angle X-ray scattering experiments and data analysis 
 To explore Ct-E88 RNA global conformational change, the small angle X-ray 
scattering (SAXS) and wide angle X-ray scattering (WAXS) data were collected at 
beam line 12-ID of the Advanced Photon Source (APS), Argonne National 
Laboratory.  The wavelength, λ, of the X-ray radiation was set to 1.033 Å. The 
detailed protocols of SAXS measurement was followed as described.
155
 In brief, the 
Ct-E88 RNA was dissolved in buffer A (100 mM HEPES/ 100 mM NaCl pH 8.0). 
The sample was heated at 90℃ for 2 min followed by cooling at room temperature 
for 10 min. MgCl2 or c-di-GMP or both, were added to buffer A to prepare two 
additional buffer conditions: buffer B (100 mM HEPES/ 100 mM NaCl pH 8.0 with 3 




and 10 μM c-di-GMP). RNA sample A was in buffer A and sample B was in buffer B. 
Sample C was in buffer C but also included extra c-di-GMP ([c-di-GMP]:[RNA] 2:1) 
and was incubated overnight at room temperature. Each RNA sample was then 
prepared in three concentrations (0.5, 1.0 and 3.0 mg/mL) making a total of nine 
sample conditions for the SAXS/WAXS data collection. 
 The q-range used for data analysis was between 0.002 and 0.300 Å
-1
. The quality 
of the SAXS data was evaluated by the linearity of the Guinier plot (a plot of [log I(q)] 
vs. q
2
, where I is intensity and q is the momentum transfer and is defined as q = 4π 
sin(θ)/λ, λ is the X-ray wavelength and the scattering angle is 2θ). WAXS data were 
used to guide the background subtraction for the corresponding SAXS data.
111, 156
 For 
each sample condition, 25 images were taken to get good statistics and each was 
converted to 1D scattering profiles. Then the resulting scattering data sets were 
averaged before buffer background subtraction using IGOR PRO (Wavemetrics) 
software. The GNOM software was used to determine the radius of gyration (Rg) 
111
, 
which were in good agreement with those obtained from Guinier approximation 




 / 3]. Pair distance distribution function (PDDF) was 
computed as an indirect Fourier transform of the scattering data using this software. 
 
7.2.5 Low resolution ab initio model reconstructions of Ct-E88 aptamer 
 The low resolution ab initio model reconstructions of Ct-E88 aptamer RNA 
under the three solution conditions described above were obtained by ATSAS 2.4 






 as described 
previously Chen et al 2012.
111




the parameter Rmax and the upper end of distance r were chosen. The resulting PDDF 
has a near-zero-value tail at large r. The maximum distances (Dmax) for each 
condition above were estimated from the PDDF. Then we used the program 
DAMMIN to obtain an approximate molecular envelope. To avoid distortion caused 
by possible underestimation of Dmax, the Rmax was set to be about 10 Å greater than 
Dmax. All reconstructions for Ct-E88 aptamer under the three conditions were 
performed in the ‘slow’ mode. DAMAVER
159
 was then used to average the resulting 
structural models and filtered dummy atom model. The normalized spatial 
discrepancy (NSD) values between each pair of models were also computed in this 
program. The model with the lowest average NSD value was chosen as the reference 
model and the remaining models were superimposed onto the reference model using 
SUPCOMB. Finally, a total of 20 independent DAMMIN runs were performed and 




7.2.6 NMR sample preparation and NMR experiments of Ct-E88 RNA 
To obtain greater insight into hydrogen-bonding interactions at Ct-E88 RNA 
binding pocket, NMR experiments were performed. The purified Ct-E88 RNA 
sample was lyophilized and dissolved in water. The corresponding amount of buffer 
stock solutions was added and the RNA sample was refolded in 30 mM HEPES-D18 / 
30 mM NaCl/ 3 mM MgCl2 pH 6.8. Then 10% D2O and saturated c-di-GMP 
(2×concentration of RNA) were added and incubated overnight at room temperature. 
For the NMR experiments, the sample concentration was ~1 mM and the final 




NMR experiments were performed on a Bruker Avance 600 MHz spectrometer. 






N HSQC on uniformly 
15
N-GTP/CTP labeled Ct-E88 RNA, and 2D NOESY 
experiments on unlabeled Ct-E88 RNA were carried out using standard pulse 
sequences at 295 K.
161
 2D homonuclear NOESY spectra used to determine imino 
proton connectivities were recorded with a mixing time of 300 ms. All spectra were 





7.3 Results and Discussion 
7.3.1 Native gel mobility shift assay 
Native PAGE is an easy and quick technique to test RNA folding and 
conformational changes upon ligand binding. If an alternative state of RNA after 
binding is present and the exchange rate between RNA in the free and bound forms 
was slow relative to the migration rate of the RNA through the gel matrix, then the 
bound RNA with different migration rates would be observed. The gel from the assay 
showed a fast migrating strong band for Ct-E88 RNA – c-di-GMP bound form and a 
weak band for RNA – endo-S-c-di-GMP bound form (Figure 7.2A), but there no 
change in migration pattern for the bands of Ct-E88 RNA binding the analogs with 
bulky modification at the 2’-OH position such as 2’-[Biotin]-AHC-c-di-GMP and 
2’-[Biotin]-endo-S-c-di-GMP (Figure 7.2B). These results were consistent with the 
equilibrium microdialysis results of different analogs binding to Ct-E88 RNA in 




that Ct-E88 RNA bound form adopted a compact conformation compared to the 
unbound RNA.  
 
Figure 7.2. Electrophoretic mobility shift assay of Ct-E88 RNA binding to different ligands. 
(A) RNA binding to c-di-GMP, endo-S-c-di-GMP, c-di-AMP, GTP and GMP. (B) RNA 




7.3.2 Selective 2’-hydroxyl acylation analyzed by primer extension (SHAPE) 
analysis of different conformations of Ct-E88 RNA  
 Next, we investigated how Ct-E88 RNA undergoes conformational change upon 
Mg
2+
 and ligand binding. Recently, SHAPE has become a valuable tool that allows 
simultaneous investigation of all nucleotides in the free and bound forms.
162, 163
 It 
would help us understand ligand-free and bound state secondary structures and the 
changes in RNA dynamics that occur upon Mg
2+ 
induced compaction and ligand 
binding. The approach employs various electrophiles such as N-methylisatoic 
anhydride (NMIA) as acylation reagent that selectively modifies 2’-OH groups within 
the regions of the RNA where the backbone is conformationally flexible (Figure 
7.3A).
153
 In contrast, nucleotides that are constrained or adopt highly structured 
tertiary interactions display low reactivity. Using this method, we investigated the 
structural changes of Ct-E88 RNA in the absence or presence of Mg
2+ 
or different 




free and bound form were observed and these regions were indicated in the different 
colors in Figure 7.3B and C. Bands intensities were quantified and absolute SHAPE 
reactivities from nucleotide position 36-89 within the Ct-E88 RNA in the different 
conditions were obtained by subtracting the (-) control intensities from the (+) NMIA 
intensities (Figure 7.4A). The predicted secondary structure based on the absolute 
SHAPE reactivities under each condition was drawn (Figure 7.4B), in which most of 
the base paired positions in RNA had lower intensities whereas single-stranded, 
bulged or mismatched nucleotide had higher intensities. 
 We found the reactivity of the various RNA elements (color coded yellow, light 
green and dark green) differed significantly in the presence and absence of Mg
2+
 
Figure 7.4A). We think the changes in the light green and dark green regions were 
likely caused by the interaction between the GNRA tetraloop within helix P2 and the 
tetraloop receptor within helix P3. Likewise the guanosine in the yellow region is 
probably involved in a tertiary G:C base pair formation as seen in Vc2 RNA (Figure 
7.3C and Figure 7.4). 
127
 These changes suggest that Mg
2+
 likely preorganizes the 





Figure 7.3. (A) Mechanism of RNA SHAPE. NMIA reacts preferentially with the 




for Ct-E88 RNA. G, A, U and C sequencing reactions were performed using cytidine, 
thymidine, adenosine and guanosine dideoxy terminating nucleotides. These marker lanes are 
one nucleotide longer than the corresponding NMIA lanes. (+) and (-) NMIA lanes represent 
reactions differing only in the presence of the reagent (See Methods). Regions that have 
significant changes in the presence of Mg
2+
 or ligand are boxed in different colors. (C) 
Predicted secondary structure of Ct-E88 RNA. The colored nucleotides correspond to the 
boxed region in the gel. (D) Known secondary structure of the ligand bound Vc2 RNA 










Figure 7.4. (A) Absolute SHAPE reactivities as a function of nucleotide position. The 
colored boxes correspond to the colored boxes in Figure 7.3. (B) The predicted secondary 
structures based on SHAPE reactivies in different conditions. The colored nucleotides 
correspond the nucleotides in the colored boxes in (A). 
 
 
 Comparison of Ct-E88 RNA bound to Mg
2+
 in the absence or presence of 
c-di-GMP (Figure 7.4A), also showed some pronounced differences. These 
differences were likely from a remolding of the binding pocket. In Ct-E88 bound 
form (Lane 2 in Figure 7.3B), SHAPE reactivity from red (A50, A51 and A52), 
purple (G23) and blue (A83, A84 and A85) regions (Figure 7.3B and C) decreased 
dramatically, indicating that c-di-GMP induced these regions into more constrained 
conformations. Combined with the predicated secondary structures of Ct-E88 from 
sequence alignment (Chapter 6, Figure 6.1), we further predicted that one of A50, 
A51 and A52 was likely involved in intercalation between adenine and two bases of 




the guanine (Gα) of c-di-GMP along the Hoogsteen face (equivalent to G20 in Vc2). 
The strong G:C base pair interaction from the other guanine (Gβ) of c-di-GMP with 
cytosine (C92) on Vc2 RNA was not very obvious from our SHAPE data. It was 
likely that Gβ of c-di-GMP formed the non-canonical Gβ:A81 base pairing interaction 
(Figure 7.4B). Also, the triple adenines A83, A84 and A85 on Ct-E88 had significant 
difference in SHAPE reactivity in the presence of c-di-GMP. It led us to tentatively 
conclude that these triple adenines (A83, A84 and A85) probably formed the adenines 
intercalating interaction with the opposite A15 to stabilize the P1 stem in the presence 
of c-di-GMP. 
 In addition, it was also noteworthy that no difference in SHAPE reactivites was 
seen for Ct-E88 RNA binding c-di-GMP analogs (endo-S-c-di-GMP, c-di-dGMP and 
c-di-2’F-GMP) when lanes 1, 3, 4, and 5 were compared, which indicated that Ct-E88 
was more discriminatory in ligand binding than Vc2. However, the details of 
hydrogen bonding interactions in Ct-E88 RNA binding pocket still remained to be 
investigated by NMR.  
 
7.3.3 Following the conformational changes of Ct-E88 aptamer induced by 
c-di-GMP and Mg
2+
 ion with SAXS 
We next tested the nature of the structural response elicited by Mg
2+
 and 
c-di-GMP using SAXS, which would provide more information on the global shape 
of the RNA in the free or bound forms. Solution scattering profiles were collected on 
Ct-E88 aptamer in the absence or presence of Mg
2+
 and c-di-GMP. The overlaid three 




exhibited significant differences, indicating the existence of three possible 
conformational states along the RNA-folding pathway (Figure 7.5A). Next, the 
SAXS data were analyzed using a Guinier plot (a plot of [log I(q)] vs. q
2
, where I is 
intensity and q is the momentum transfer and is defined as q = 4π sin(θ)/λ, λ is the 
X-ray wavelength and the scattering angle is 2θ). From the scattering data, the radius 
of gyration (Rg) was fit at low q values using the linear, first-order Guinier 




 / 3. The data suggested that Rg of Ct-E88 
aptamer compacted in response to both Mg
2+
 and c-di-GMP (Table 7.1). In the 
absence of Mg
2+
 and c-di-GMP (U state), the RNA adopted an extended conformation 
with an Rg of 29.5 Å. In the presence of 3 mM Mg
2+ 
(I state), Rg decreased to 28.9 Å 
which was correlated to the preorganized intermediate state (I). In the presence of 
both Mg
2+
 and c-di-GMP (B state), RNA was further compacted to the Rg at 24.3 Å. 
To further highlight the degree of RNA compaction, SAXS data were compared in 
Kratky representations (Figure 7.5B), where the scattering intensity is weighted by 
the square of the momentum transfer (q). It was seen that the scattering curve of RNA 
in U state exhibited a flattened plateau with scattering intensity falling slightly at 
large angle, suggesting that the unbound (U state) Ct-E88 RNA was locally 
disordered.  Although it is different from an upward rising scattering intensity 
representative of a completely denatured conformation according to Porod’s law, this 
U state is consistent with a partially ‘folded state’ with an extended conformation.
164
 
Compared to the U and I states, B state had a pronounced concave peak indicative of 
the folded structure. To provide more information on the shape and maximum 




plots were compared (Figure 7.5C).
165, 166
 It was seen that RNA in U and I states 
(Table 7.1) had relative larger maximum intramolecular distance Dmax than the 
RNA-c-di-GMP bound state (B). This observation revealed a marked ligand-induced 
compaction of the RNA in the presence of Mg
2+
, likely indicative of folding of the 
c-di-GMP binding pocket.  
 
Figure 7.5. SAXS analysis of Ct-E88 RNA under three different states. (A) Comparison of 
experimental scattering profiles of Ct-E88 RNA. (B) Comparison of the SAXS data in Kratky 
representation for Ct-E88 RNA under the three states. (C) Comparison of P(r) plot 






Structural properties of Ct-E88 RNA under different conditions 
States Conditions Rg (Å) Dmax (Å) NSD 
Unfolded (U) Buffer 29.5 ± 0.2 106 0.95 ± 0.02 
Intermediate (I) Buffer + 3 mM Mg
2+ 
28.9 ± 0.1 106 0.74 ± 0.04 
Bound (B) Buffer + Mg
2+
 + c-di-GMP 24.3 ± 0.1 81 0.60 ± 0.03 
 
Table 7.1. Parameters and quality indicators derived from the x-ray scattering data for the 
Ct-E88 aptamer under different conditions. The radius of gyration (Rg) values were obtained 
from Guinier analysis of the low angle scattering data, the maxium intramolecular distances 
(Dmax) were obtained using GNOM program and the NSD values of three low resolution 
reconstruction models were generated from DAMAVER program.  
 
7.3.4 Low resolution ab initio modeling of Ct-E88 RNA 
 To gain further insight into the nature of the Mg
2+
 and c-di-GMP – induced 
conformational change, we constructed low resolution ab initio models of Ct-E88 
RNA in the three states based on the SAXS data using the program DAMMIN
158
 as 
described in Chen et al 2012.
111
 The program package DAMAVER
159
 was used to 
average the resulting 20 models for each sample condition. The NSD between each 
pair of models was computed and listed in Table 7.1. It provides a quantitative 
estimate of similarity between models, where identical models give NSD values at 
zero, similar models give NSD values around one and models with different shapes 
give NSD values greater than one.
167
 The final low-resolution reconstruction obtained 
was the average molecular envelope of the ensemble. Here the average NSDs for the 
three reconstructions were 0.95, 0.74 and 0.60 (each NSD was <1) (Table 7.1), 




model ensembles for Ct-E88 RNA under these three states. B state had the lowest 
average NSD value, consistent with the most rigid and folded surface as we expected. 
 The low resolution models corresponding to the three states of Ct-E88 RNA were 
presented in Figure 7.6, They were shown in different views of the final surface of 
the ab initio models (molecular envelope) as mesh representations with ‘filtered’ 
models inside the molecular envelopes indicated in beads. Comparison of the low 
resolution models of these three states indicated that the unfolded state had four arms, 
and then two of them were merged into one arm in the I state. Further folding into a 
compact conformation occurred in the presence of c-di-GMP. This observation was 
likely similar to the proposed folding pathway of Vc2 RNA from smFRET 
analysis.
127
 Herein helices P2 and P3 are packed side-by-side through tetraloop and 
tetraloop receptor interaction in the presence of Mg
2+
, but P1 is not yet formed. This 
Mg
2+
-dependent state offers a preorganized intermediate state that would allow more 
efficient binding of c-di-GMP. Thus c-di-GMP binding would likely promote the 










Figure 7.6. Low-resolution ab initio models of Ct-E88 aptamer under three different folding 
states (U state in blue, I state in red and B state in green). Three different views are shown for 
the final consensus models (molecular envelope) as mesh representatives with ‘filtered’ 
models as beads aligned inside. 
 
 
7.3.5 NMR titration study of Ct-E88 RNA with c-di-GMP 
 Next, NMR titration experiments were performed to determine whether the Mg
2+
 
ion and c-di-GMP induced structural rearrangements resulted in any changes of 
hydrogen-bonding interactions in Ct-E88. 
 First, 1D NMR chemical shift perturbation experiment is a simple method to 
compare the binding sites in biomolecular complexes. Before running the titration of 
Ct-E88 RNA with c-di-GMP experiments, the stability of Ct-E88 RNA molecules 
was investigated by following temperature-induced changes in the imino region of the 
1D 
1




showed the most peaks in the imino region, suggesting that it is the most optimized 
folding temperature condition. Therefore, 295 K was used for further titration 
experiments. Since the chemical shifts of the imino proton resonances in RNA 
strongly depend on its chemical environment, including base pairing, base stacking, 
ring current and hydrogen bonding to solvent molecules, the characteristic imino 
proton and the formation and breakage of canonical or non-canonical base pairs could 
be monitored to define conformational changes upon interacting with ligands.
168
 The 
titration of Ct-E88 RNA with c-di-GMP in the presence of Mg
2+
 ion from 1D 
1
H-NMR spectra, in the imino region, revealed that there were significant chemical 
shift perturbations of existing imino peaks and appearance of some strong new peaks 
(Figure 7.8), where the peaks in the region of 12-15 ppm were usually indicative of 
canonical Watson-Crick base pairs (A:U and G:C base pairings) and upfield chemical 
shifting peaks at 10-12 ppm were often indicative of noncanonical base pairs (G:U, 





Figure 7.7. Imino region of 1D 
1







Figure 7.8. The imino region of 1D 
1
H NMR spectra of Ct-E88 RNA with 3 mM Mg
2+
 in the 






Second, 2D nuclear Overhauser effect spectroscopy (NOESY) experiment which 
correlates all pairwise protons within 5 Å would further provide us with more 
information on base pairing and secondary structure. From the 2D-imino region of the 
NOESY spectra depicting titration of CtE88-RNA with c-di-GMP, it was found that 
there was one non-canonical cross peak (G:U or G:A) at 10-12 ppm and some 
canonical cross peaks (G:C or A:U) at 12-15 ppm in the absence of c-di-GMP.
169
 
However, not many more cross peaks were seen when c-di-GMP was added, 
indicating some limited conformational change and transformation to a well-folded 
structure. While there were less cross peaks than we expected from SHAPE data 








Figure 7.9. The imino region of 2D-NOESY of RNA with 3 mM Mg
2+
 (A) in the presence or 
(B) absence of c-di-GMP. (C) Overlay of (A) and (B). Temperature is at 295K. The new 
peaks that appeared in the bound form are circled in green. 
 
 
 Third, uniformly 
15
N – labeled GTP and CTP with unlabeled UTP and ATP 
Ct-E88 RNA sample was prepared and heteronuclear single quantum correlation 
(HSQC) experiments were recorded. In the free and c-di-GMP bound Ct-E88 RNA 
(Figure 7.10), we respectively observed 5 and 10 guanine imino resonances in the 
region between 12-13.5 ppm of the 
1
H-spectrum for RNA characteristic of G:C 
Watson-Crick base pair formation. In the region between 9-11 ppm for RNA 
characteristic of noncanonical base pairing (GU, GA or GG), we found 2 and 4 
guanine resonances in the free and bound Ct-E88 RNA respectively. These results 
suggested that Mg
2+
 helped RNA preorganize into a partial folded form and 
c-di-GMP binding stabilized it into a more folded structure. Some overlapped peaks 
between free and bound forms indicated that some base pair interactions in the free 





Figure 7.10. Imino HSQC NMR experiment of the 
15
N-GTP, CTP labeled Ct-E88 RNA in 
the presence (red) or absence (blue) of unlabeled c-di-GMP. 
 
 
 Although our preliminary NMR data provided limited information on 
conformational change of Ct-E88 RNA recognition of ligand, details of hydrogen 
bonding interactions in the binding pocket are still unknown. Further heteronuclear 
2D HSQC and HNN-COSY with different labeled sample will help to characterize 
the peaks and elucidate more details of base pairing and conformational change. Due 
to the large size problem of Ct-E88 RNA in NMR experiment, we will also make a 
new construct with two annealed pieces as the one used in smFRET for Vc2 RNA
127
 
and specifically label each piece using our new developed labeling techniques
170-172
 to 
provide greater insights into the nature of secondary and tertiary structure and how 





 In this study, we characterized the Ct-E88 riboswitch under different folding 
conditions using SHAPE, SAXS and NMR. Our preliminary data demonstrates that 
Ct-E88 aptamer adopts multiple conformations upon Mg
2+
 and c-di-GMP binding. 
Mg
2+
 ion, as an essential cofactor, facilitates RNA pre-organized folding for 
c-di-GMP binding. However, ligand binding further stabilizes the tertiary structure 
into compact fold to regulate the downstream gene. The details of hydrogen bonding 
interactions in the binding pocket still remain to be investigated by NMR. By 
combining future NMR experiments with present SHAPE and SAXS data, we will 
obtain greater insights into the nature of secondary and tertiary structural 
rearrangement of RNA in the presence of Mg
2+
 and c-di-GMP and perhaps better 











Chapter 8: Conclusions and future work – C-di-GMP riboswitch 
8.1 Conclusions 
 The second part of this dissertation focused on the study of c-di-GMP riboswitch 
RNA. C-di-GMP riboswitch is the regulatory mRNA found in bacterial 3’- or 
5’-UTRs (untranslated region), and it can directly sense the secondary messenger 
c-di-GMP using its aptamer domain to modulate downstream gene expression.
102
 Due 
to the central role that c-di-GMP plays in bacterial biofilm formation and virulence, 
there is interest in inhibiting c-di-GMP signaling pathways in specific bacteria in 
polymicrobial systems through riboswitch regulation. We hypothesized that even 
within the same class, different riboswitches would use different recognition elements 
to sense c-di-GMP. Therefore there is an opportunity to selectively target different 
bacteria, which harbor different c-di-GMP riboswitches, with selective small 
molecules. To test this hypothesis, we designed and synthesized different c-di-GMP 
analogs and investigated whether they would be differentially recognized by 
riboswitches that belong to different classes (Chapter 5) or within the same class 
(Chapter 6). We also used a panel of biophysical techniques (NMR, SAX, SHAPE, 
gel shift) to gain some insights into the conformations of class I riboswitches 
(Chapter 7). 
 In Chapter 5, we demonstrated, using molecular docking and equilibrium 
microdialysis experiments, that 2’-OH modified analogs of c-di-GMP are probes to 
tell apart c-di-GMP class II riboswitches from class I. In Chapter 6, we further 




to the RNAs could also be very different. However, more optimized analogs to 
selectively target one particular class or subclass of riboswitches to inhibit c-di-GMP 
signalling in some pathogenic but not symbiotic bacteria still remain to be developed. 
 Secondly, we chose one sub-class I c-di-GMP riboswitch from Clostridium tetani 
(Ct-E88), which has large differences in binding affinities of c-di-GMP analogs to the 
known class I Vc2 RNA, for structural study. Such a study will help us understand 
how the ligand finds its binding pocket and triggers the conformational change to 
modulate the downstream genes in the expression region of the riboswitch. To this 
end, we used three different biochemical and biophysical tools: selective 2’-hydroxyl 
acylation analyzed by primer extension (SHAPE) to characterize the secondary 
structure of free or bound forms, small-angle X-ray scattering (SAXS) to explore the 
global shape of the RNA in the free or bound forms, and nuclear magnetic resonance 
(NMR) to study the H-bonding interaction between the RNA and the ligand. Our 
results showed that the RNA is pre-organized for efficient ligand binding in the 
presence of Mg
2+
 ion. Subsequently ligand binding stabilizes the tertiary structure and 
formation of P1 stem to regulate the downstream gene. However, further details of 
hydrogen bonding interactions in the binding pocket are still unknown, and NMR will 
be needed to fill in these critical gaps in knowledge. It will not only provide details in 
the nature of secondary and tertiary structural arrangement of the RNA but also help 





8.2 Future work 
 This work has demonstrated that it is indeed possible to differentiate between 
c-di-GMP riboswitches with small molecules. Future work could investigate how to 
specifically target c-di-GMP riboswitches in pathogenic, but not symbiotic, bacteria. 
Towards this end, two approaches could be adopted: a) modifying c-di-GMP into a 
pathogen-selective c-di-GMP analog and converting this analog into a cell-permeable 
pro-drug; b) designing non-c-di-GMP small molecule inhibitor of riboswitches, using 
structural data obtained from NMR and X-ray crystallography. It would therefore be 
fruitful to structurally characterize the new class I c-di-GMP riboswitches (Ct-E88 
and Cb-E43) that were experimentally verified to bind to c-di-GMP. The structural 
characterization of these analogs, with and without c-di-GMP or analogs, would 
provide atomistic details of the binding site, which could be used to design 






Appendix 1: Spectra for PC-alkyne (Chapter 2) 
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Appendix 2: Spectra for PC-alkyne GMP (Chapter 2) 
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Appendix 3: Spectra for biotin-PC-GMP (Chapter 2) 
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Appendix 4: Different ligands docking into Vc2 (Chapter 5) 
 
(c-di-GMP, endo-S-c-di-GMP, compound 5) and compound 6) docking into Vc2 
RNA (PDB: 3IRW). The different conformers of each ligand were optimized using 
Gaussian with fixed C5’-C5’ distance of two guanines. Dockings were done in 
triplicate for each c-di-GMP and analog conformers.  
 
Ligand Distance (Å) between 
C5 of two guanines in 
Gaussian optimized 
structure 
Distance (Å) between C5 of 
two guanines after docking 
Docked binding 
affinity (kcal/mol) 
c-di-GMP 5.5 5.81 5.82 5.82 -12.2 -12.2 -12.2 
6.5 6.12 6.10 6.10 -11.8 -11.8 -11.8 
6.6 6.46 6.46 6.46 -14.6 -14.6 -14.7 
6.7 6.51 6.51 6.51 -15.1 -15.1 -15.1 
6.8 6.46 6.46 6.45 -13.6 -13.6 -13.5 
6.9 6.93 6.65 6.65 -11.3 -16.2 -16.2 
7.0 6.71 7.00 6.72 -16.7 -11.3 -16.7 
7.1 6.79 6.79 6.79 -17 -17.1 -17 
7.2 6.85 6.86 6.86 -17.1 -17.3 -16.9 
7.3 6.93 6.92 6.93 -17.4 -17.4 -17.4 
7.4 6.99 6.99 6.99 -17.5 -17.5 -17.5 
7.5 6.92 6.93 6.92 -16.9 -16.9 -16.9 
7.6 7.13 7.13 7.13 -17.5 -17.5 -17.5 
7.7 7.20 7.20 7.20 -17.3 -17.4 -17.4 
7.8 7.28 7.28 7.28 -17.1 -17 -17.1 
7.9 7.35 7.35 7.35 -16.7 -16.7 -16.7 
8.0 7.42 7.43 7.42 -16.2 -16.1 -16.2 
8.5 7.48 7.46 7.45 -12.5 -12.5 -12.5 
9.5 7.75 8.37 8.37 -10.4 -11.4 -11.3 
endo-S-c-di-GMP 5.5 5.75 5.75 5.75 -11.1 -11.1 -11.2 
6.0 6.12 6.11 6.12 -11.5 -11.5 -11.5 
6.5 6.87 6.88 6.88 -13.1 -13 -13 
6.6 6.95 6.95 6.95 -13.3 -13.3 -13.2 
6.7 7.17 7.17 7.17 -13.1 -13.2 -13.1 
6.8 7.12 7.12 7.12 -12.6 -12.6 -12.6 
6.9 7.18 7.19 7.19 -13.9 -13.9 -13.9 
7.0 7.27 7.27 7.27 -13.9 -13.9 -13.9 




7.2 7.43 7.43 7.43 -14 -14 -13.9 
7.3 7.50 7.50 7.50 -13.9 -13.9 -13.9 
7.4 7.57 7.57 7.57 -13.9 -13.9 -13.9 
7.5 7.66 7.74 7.66 -12.6 -12.6 -12.6 
7.6 7.88 8.36 7.88 -12.3 -11.7 -12.3 
7.7 7.96 7.96 7.96 -12 -12 -12 
7.8 7.20 7.21 7.20 -13.5 -13.5 -13.5 
7.9 7.95 7.95 7.95 -12.9 -12.9 -12.9 
8.0 8.03 8.03 8.03 -12.5 -12.5 -12.5 
8.5 8.62 7.65 8.61 -11.3 -12.8 -11.2 
9.5 8.71 8.71 8.72 -12.1 -12.1 -12.1 
Compound 5 
(model for 2’-[Biotin]- 
endo-S-c-di-GMP) 
5.5 7.50 7.19 7.18 -11.2 -11.3 -11.2 
6.5 6.73 6.73 6.73 -11.2 -11.2 -11.2 
6.8 7.00 6.99 7.00 -11.4 -11.3 -11.4 
6.9 7.09 7.09 7.09 -11.4 -11.4 -11.4 
7.0 7.20 7.20 7.20 -11.4 -11.4 -11.4 
7.1 7.20 7.20 7.20 -11.4 -11.4 -11.4 
7.2 7.41 7.41 7.41 -11.2 -11.2 -11.2 
7.3 7.53 7.53 7.53 -10.6 -10.8 -10.6 
7.4 7.48 7.62 7.48 -11.1 -10.5 -11.1 
7.5 7.68 7.68 7.68 -11.7 -11.7 -11.7 
7.6 7.84 7.84 7.84 -11.6 -11.6 -11.5 
7.7 7.98 7.98 7.98 -11.6 -11.6 -11.6 
7.8 9.26 9.26 9.26 -11.5 -11.5 -11.5 
8.0 9.48 9.48 9.48 -11.7 -11.6 -11.7 





-10.2 -10.9 -11.3 
Compound 6 
(model for 2’-[Biotin] 
-AHC-c-di-GMP 
5.5 6.52 6.52 6.52 -9.7 -9.7 -9.7 
6.5 6.08 6.09 6.08 -10.2 -10.1 -10.1 
6.8 6.35 6.35 6.35 -10.1 -10.1 -10.1 
6.9 7.56 7.59 7.55 -10.4 -10.3 -10.3 
7.0 7.67 7.73 7.67 -10.3 -10.3 -10.4 
7.1 7.78 7.80 7.85 -10.2 -10.2 -10.1 
7.2 7.87 7.88 8.05 -10.2 -10.2 -10.2 
7.5 7.98 8.00 8.05 -10.6 -10.6 -10.5 
8.0 8.43 8.55 8.56 -10.4 -10.5 -10.6 
8.5 9.24 9.23 8.40 -11.7 -11.7 -9.8 




Appendix 5: Different ligands docking into CdA. (Chapter 5) 
 
Different ligands (c-di-GMP, endo-S-c-di-GMP, compound 5) and compound 6) 
docking into CdA RNA (PDB: 3Q3Z). The different conformers of each ligand were 
optimized using Gaussian with fixed C5’-C5’ distance of two guanines. Dockings 
were done in triplicate for each c-di-GMP and analog conformers. 
 
Ligand Distance (Å) between C5 of 
two guanines in Gaussian 
optimized structure 
Distance (Å) between C5 




c-di-GMP 5.5 5.97 5.97 5.97 -10.1 -10.1 -10.1 
6.5 6.5 6.5 6.5 -10.1 -10.1 -10.8 
6.6 6.6 6.6 6.6 -12.5 -12.5 -12.5 
6.7 6.7 6.7 6.7 -13.1 -13.1 -13 
6.8 6.7 6.8 6.7 -12.9 -12.9 -12.9 
6.9 6.8 6.8 6.8 -14 -14 -14 
7.0 6.9 6.9 6.9 -14.3 -14.3 -14.3 
7.1 7.0 7.0 7.0 -14.6 -14.6 -14.6 
7.2 7.0 7.0 7.0 -14.7 -14.7 -14.7 
7.3 7.1 7.1 7.1 -14.8 -14.8 -14.8 
7.4 7.2 7.2 7.2 -14.7 -14.7 -14.7 
7.5 7.2 7.2 7.2 -15.1 -15.1 -15.1 
7.6 7.3 7.3 7.3 -14.4 -14.4 -14.4 
7.7 7.4 7.4 7.4 -14.2 -14.2 -14.2 
7.8 7.4 7.4 7.4 -13.9 -13.9 -13.9 
7.9 7.5 7.5 7.5 -13.5 -13.5 -13.5 
8.0 7.6 7.6 7.6 -13.1 -13.1 -13.1 
8.5 7.6 7.6 7.6 -13.4 -13.4 -13.4 
9.5 8.1 8.1 8.1 -13.1 -13.1 -13.2 
endo-S-c-di-GMP 5.5 5.5 5.5 5.5 -9.5 -9.5 -9.5 
6 5.8 5.8 5.8 -9.7 -9.6 -9.7 
6.5 6.4 6.4 6.4 -9.8 -9.8 -9.8 
6.6 6.4 6.5 6.4 -9.8 -9.8 -9.8 
6.7 7.4 7.4 7.4 -9.8 -9.8 -9.8 
6.8 6.7 6.7 6.7 -10.7 -10.7 -10.6 
6.9 7.5 7.5 7.5 -9.9 -9.8 -9.9 
7 7.5 7.5 7.5 -9.9 -9.9 -9.9 
7.1 7.6 7.6 7.6 -9.9 -9.9 -9.9 
7.2 7.7 7.7 7.7 -9.9 -9.9 -9.9 
7.3 7.1 7.1 7.1 -10 -10 -10 




7.5 7.7 7.7 7.7 -10.9 -10.9 -10.9 
7.6 8.1 8.1 8.1 -10.1 -10.1 -10.1 
7.7 8.2 8.2 8.2 -10.1 -10.1 -10.1 
7.8 8.2 8.2 8.3 -10.1 -10.1 -10.1 
7.9 7.3 7.3 7.3 -11.1 -11.1 -11.1 
8 7.4 7.4 7.4 -11.1 -11.1 -11 
8.5 7.9 7.9 8.0 -11.3 -11.3 -11.3 
9.5 9.2 9.2 9.2 -10.7 -10.7 -10.7 
Compound 5 
(model for 2’-[Biotin]- 
endo-S-c-di-GMP) 
5.5 6.6 6.8 6.6 -9.8 -10 -9.8 
6.5 7.5 7.5 7.5 -10 -10 -10 
6.6 7.4 7.6 7.6 -10.4 -10 -10 
6.7 7.4 7.4 7.4 -10.5 -10.8 -10.5 
6.8 7.5 7.5 7.5 -10.9 -11 -10.9 
6.9 7.6 7.6 7.6 -10.8 -10.9 -10.9 
7 7.7 7.7 7.7 -11.1 -11 -10.9 
7.1 7.7 7.7 7.7 -11 -11 -10.9 
7.2 8.1 8.1 8.1 -10.3 -10.3 -10.3 
7.3 8.2 8.2 8.2 -10.2 -10.2 -10.2 
7.4 8.3 8.3 8.3 -10.3 -10.3 -10.3 
7.5 8.8 8.8 8.8 -11.4 -11.4 -11.4 
7.6 9.0 9.0 9.0 -10.5 -10.5 -10.5 
7.7 9.1 9.1 9.1 -10.4 -10.4 -10.4 
7.8 9.2 9.2 9.2 -10.3 -10.3 -10.3 
8 9.4 9.4 9.4 -10 -10 -10 
8.5 9.4 9.4 9.4 -11.1 -11.1 -11.1 
9.5 10.4 10.4 10.4 -11 -11 -11 
Compound 6 
(model for 2’-[Biotin] 
-AHC-c-di-GMP 
5.5 6.4 6.4 6.5 -8.8 -8.8 -8.9 
6.5 7.4 7.4 7.4 -10 -10 -10 
6.8 7.0 7.0 7.0 -8.6 -8.7 -8.6 
6.9 8.0 8.0 8.0 -9.1 -9.1 -9.1 
7 8.1 8.1 8.1 -9.2 -9.2 -9.2 
7.1 8.2 8.2 8.2 -9.3 -9.3 -9.3 
7.2 8.3 8.3 8.3 -9.4 -9.4 -9.4 
7.5 8.3 8.3 8.3 -9.2 -9.2 -9.2 
8 8.9 8.9 8.9 -9.4 -9.4 -9.4 
8.5 9.4 9.4 9.4 -10.5 -10.5 -10.5 





Appendix 6: Binding curves from gel-shift assay (Chapter 6) 
 
I. Binding curves of RNA with c-di-GMP 
 








II.  Competitive displacement curves of RNA with 2’-H-c-di-GMP 
 







III.  Competitive displacement curves of RNA with 2’-F-c-di-GMP 
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